+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 67675

Chapter 67675 contains a list of PDF Full Texts available from EurekaMag.





Magg, J.; C., L.; P., E.; P., G.; K., A.; S., M.; M., R.; R., O.; N., H., 2012:
B12The influence of kalirin-7 deficiency on the phenotype of Yac128 mice

Zala, D.; H., V.; L., G.; P., P.; H., S.; S., F., 2012:
B13axonal transport, energy supply and huntingtin

Quarrell, O., 2012:
A03Juvenile Huntington's disease

Ben M'Barek, K.; O., S.; P., P.; B., C.; G., J.; G., A.; S., F.; D., D.; H., S., 2012:
B14Huntingtin mediates anxiety/depression-related behaviours in mouse through Bdnf transport and hippocampal neurogenesis

Pepers, B.; Mastrokolias, A.; van Ommen, G.J.B.; den Dunnen, J.; Hoen, P.; van Roon-Mom, W., 2012:
B15Ctcf in Huntington's disease

Priller, J.; N., C.; B., Y.; G., M.; F., R.; B., J.; Z., C.; L., M.; W., E., 2012:
B16Collapsin response mediator protein 4 downregulates aggregation and toxicity of mutant huntingtin

van der Goot, A.; Zhu, W.; Seinstra, R.; Krijnen, J.; Ruiz Silva, M.; Thijssen, K.; Oefner, P.; Kema, I.; Nollen, E., 2012:
B17 Delaying ageing and the ageing-associated decline in protein homeostasis by inhibition of tryptophan degradation

Squitieri, F.; D.Pardo, A.; A., S.; M., V.; C., A., 2012:
B18Glucose metabolism is reduced in Huntington disease: in-vivo and in-vitro evidence

Nielsen, S.; Josefsen, K.; F., L.; Køhler, L.; N., A.; H., L., 2012:
B19Lactate metabolism in the Huntington's disease mouse model R6/2

Schneider, N.; T., D.; L., G.; Orth, M.; F.-Posovszky, P.; L., K., 2012:
B20Increased glucose uptake in white adipose tissue of R6/2 mice due to changes in expression and translocation of glucose transporter 4 (Glut4)

Wackler, P.; L., T.; H., T.; O., M.; L., G.; Lindenberg, K., 2012:
B21Decreased expression and reduced translocation to the sarcolemma of the insulin-sensitive glucose transporter Glut4 in skeletal muscle of R6/2 Mice

Magnusson-Lind, A.; D., M.; S.ć, E.; Hansen, C.; T., S.; Björkqvist, M., 2012:
B22Does a peripheral immune response influence muscle pathology in Huntington's disease?

Träger, U.; A., R.; L., N.; M., A.; P., E.; W., A.; G., S.; A., M.; B., G.; M., P.; B., M.; O., G.; A., N.; T., S., 2012:
B23Immune dysfunction in Hd human myeloid cells is caused by NfB pathway dysregulation and is reversed by lowering Htt levels

Wolf, R.; Sambataro, F.; V., N.; W., N.; Thomann, P.; Saft, C.; L., G.; Orth, M., 2012:
A04Default-mode network changes in preclinical Huntington's disease

Murphy, K.; Dallerac, G.; Milnerwood, A.; Cummings, D.; Vatsavayai, S.; Stramek, A.; E., K.; Walters, S.; Hirst, M., 2012:
B24Dysfunctional dopaminergic neurones and biphasic activity-dependent dopamine release in mouse models of Huntington's disease

Jahanshahi, A.; V., R.; Z., D.; S., H.; T., Y., 2012:
B25Hyperdopaminergic status in Huntington's disease

Kantor, S.; C., M.; M., A., 2012:
B26Sleep and Eeg abnormalities in Huntington's disease mice

Kalliolia, E.; K., R.; S., E.; N., R.; H., N.; H., P.; B., M.; W., T., 2012:
B27Disruption of melatonin circadian rhythmicity in Huntington's disease (Hd)

Ouk, K.; A., J.; Cuesta, M.; M., A., 2012:
B28Neural mechanisms underlying the dysfunction of the methamphetamine-sensitive circadian oscillator (Masco) in a mouse model of Huntington's disease

Aungier, J.; C., M.; M., A., 2012:
B29Voluntary exercise improves circadian function in a mouse model of Huntington's disease

Hult, S.; S., R.; P., ., 2012:
B30Expression of mutant huntingtin in leptin receptor-expressing neurons does not influence the metabolic phenotype and psychiatric-like features in Huntington's disease

Soylu, R.; P., ., 2012:
B31Deletion of mutant huntingtin expression in sim1 neurons in the Bachd mouse model of Huntington's disease

Hölzner, E.; B., M.; N., N.; M., M.; W., N.; B., S.; F., C.; M., J.; R., R., 2012:
C01Track-Tghd Minipigintroduction of a longitudinal tgHd minipig phenotyping study using Mri, motor and cognitive endpoints

Zizkova, M.; H., R.; J., J.; J., S.; H., P.; K., H.; M., J., 2012:
C02-catenin expression in minipigs transgenic for human mutated huntingtin

Georgiou-Karistianis, N.; S., J.; P., G.; G., M.; D., J.; C., A.; C., P.; E., G., 2012:
A05Longitudinal functional and connectivity changes during working memory performance in Huntington's disease: the image-Hd study

Benova, I.; K. Skalnikova, H.; K., J.; J., S.; M., J., 2012:
C03Activation of cytokine production in F1 and F2 generation of miniature pigs transgenic for N-terminal part of mutated human huntingtin

Mačáková, M.; H., H.; A., P.; H., Z.; S., J.; J., S.; J., J.; B., M.; Z., J.; M., J., 2012:
C04Reproductive parameters and mitochondrial function in spermatozoa of F1 and F2 minipig boars transgenic for n-terminal part of the human mutated huntingtin

Yu, L.; P., E.; Osmand, A.; Redensek, A.; M., S.; C., L.; Park, L.; H., D.; C., C.; G., X.; P., B.; Y., X.; Riess, O.; N., H., 2012:
C05A novel Bachd transgenic rat exhibits characteristic neuropathological features of Huntington disease

Portal, E.; N., H., 2012:
C06Phenor: data exploration for automated homecage system

Jansson, E.; M., N.; Doyère, V.; Y., L.; R., O.; N., H., 2012:
C07Skinner box test for strategy shifting impairments in Bachd rats

Abada, Y.; N., H.; Schreiber, R.; E., B., 2012:
C08Motor, cognitive and emotional investigation in a novel rat model of Huntington's disease

Gabery, S.; S., M.; Hult, S.; S., R.; K., D.; P., ., 2012:
C09Characterisation of a rat model of Huntington's disease based on targeted expression of a mutant huntingtin fragment in the forebrain using an adeno-associated viral vector

Kelp, A.; K., A.; Petrasch-Parwetz, E.; C., C.; B., C.; B., P.; R., O.; N., H., 2012:
C10Generation and characterisation of a transgenic rat model of huntington's disease-like 4 (Hdl4), also called spinocerebellar ataxia type 17 (Sca17)

Paucar, M.; W., E.; W., R.; Svenningsson, P., 2012:
D02A case of Huntington disease-like 1 (Hdl1) with long disease duration

't Hart, E.; M., H.; B., J.; Bentivoglio, A.; Craufurd, D.; R., R.; S., C.; R., R., 2012:
A06Better global and cognitive functioning for choreatic compared to hypokinetic-rigid huntington's disease

Brauner, H.; M., S.; R., O.; N., H., 2012:
E01Analysis of mitochondrial genes as potential genetic modifiers of the age-at-onset in Huntington disease

Kloster, E.; S., C.; A., L., 2012:
E03Association study of cannabinoid receptor gene (Cnr1) polymorphisms and age at onset in Hd

Futter, C.; M., S.; S., M.; T., L.; R., O.; N., H., 2012:
E04Autophagy-related gene Atg7 is a genetic modifier of Aao specific in the Italian population

Tunali, N., 2012:
E05Age of onset of Huntington's disease is not modulated by Hcad R196K polymorphism

Hughes, A.; Rosser, A.; J., L., 2012:
E06Family history curation in Huntington's disease: a survey of the data so far

Sajjad, M.; Pinard, G.; F., C.; I., C.; P., .; Kirik, D., 2012:
F01Establishment of novel assays for quantification of full-length wild-type and mutant huntingtin by using the alphalisa technology

Westerberg, G.; Massai, L.; Magnoni, L.; Pollio, G.; Tripepi, G.; Diodato, E.; Caricasole, A.; Bernocco, S.; Tabrizi, S.; Landwehrmeyer, B., 2012:
F02 Selisistat: soluble Htt protein levels as a potential pharmacodynamic readout

Westerberg, G.; D., D.; P., G.; M., E.; F., C.; M., E.; M., L.; T., A.; M., F.; T., S.; Landwehrmeyer, B.; C., A., 2012:
F04Selisistat: potential pharmacodynamic readouts based on transcriptomics

Long, J.; Paulsen, J.; Zhang, Y.; K., J.; Mills, J.; Liu, W., 2012:
A07Critical consideration of the criteria for the motor diagnosis of huntington disease

Andre, R.; W., A.; T., U.; G., S.; F., R.; L., C.; S., R.; L., N.; H., S.; M., D.; F., C.; B., G.; B., G.; K., R.; W., E., 2012:
F05Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression

Silajdžić, E.; Lahiri, N.; W., E.; Tabrizi, S.; Björkqvist, M., 2012:
F06A critical evaluation of inflammatory markers in Huntington's disease plasma

Bouwens, J.; H., M.; van der Mast, R.; R., R.; van Duijn, E.; G., E., 2012:
F07Cross-sectional and longitudinal associations between Crp and neuropsychiatric symptoms in Hd

Goehler, H.; K., A.; T., M.; S., C.; M., H.; Lueking, A.; S., V.; W., D.; H., R.; G., R.; S., C., 2012:
F08The autoimmune profile of Huntington's disease patients: a pilot study

Krzyszton-Russjan, J.; Zielonka, D.; Jackiewicz, J.; Kusmirek, S.; Bubko, I.; Klimberg, A.; Marcinkowski, J.; Anuszewska, E., 2012:
F09 The study on molecular changes related to energy metabolism in Huntington's disease subjects: looking for biomarkers

Valerio, L.; D.Donato, S.; L., J.; J., A.; P., J., 2012:
F13Progressive reduction of plasma 24S-hydroxycholestrol in prodromal Hd subjects according with clinical and Mri features in the Predict-Hd study

Borowsky, B.; W., J.; M., W.; J., H.; D., A.; R., R.; T., S.; Leavitt, B.; B., C.; T., A.; S., H., 2012:
F148OhdG is not a biomarker for Huntington's disease; lessons for future biomarker studies

Nance, M., 2012:
A08Clinical management of Huntington's disease

Kopishinskaya, S.; Antonova, V.; Gustov, A.; Prodonets, N., 2012:
F15A new biomarker in Huntington's disease

Hobbs, N.; Cole, J.; F., R.; Rees, E.; Scahill, R.; Crawford, H.; Roos, R.; Sprengelmeyer, R.; D., A.; L., B.; T., S.; Frost, C., 2012:
G01Evaluation of multi-modal, multi-site imaging measures in Huntington's disease: baseline results from the Paddington study

Wolf, R.; Thomann, P.; Thomann, A.; Vasic, N.; W., N.; Landwehrmeyer, G.; Orth, M., 2012:
G02Brain structure in preclinical Huntington's disease: a multi-method approach

Crawford, H.; Hobbs, N.; Cole, J.; R., E.; Owen, G.; L., D.; Frost, C.; L., B.; R., R.; C., D.; S., J.; Durr, A.; L., B.; R., R.; Tabrizi, S., 2012:
G03Corpus callosal atrophy in Huntington's disease

Nopoulos, P.; E., E.; C., A.; M., K.; P., J.; S., B.; P., J.; B., J.; M., V., 2012:
G04Brain structure in children at risk for Huntington's disease

Sánchez-Castañeda, C.; di Paola, M.; E., F.; M., V.; di Pardo, A.; S., U.; S., F., 2012:
G05Alterations in iron content in the brain of Huntington disease mutation carriers in comparison with healthy control subjects

Novak, M.; S., K.; G., C.; C., C.; T., S., 2012:
G09Structural connectivity-based topography of the basal ganglia is altered in premanifest and early manifest Huntington's disease

Walker, R., 2012:
A09The differential diagnosis of chorea

Syka, M.; K., J.; K., J.; Rulseh, A.; Roth, J.; J., R.; V., I.; V., J., 2012:
G10Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington disease patients

Phillips, O.; Sanchez-Castaneda, C.; C., C.; D.Pardo, A.; M., V.; S., F.; S., U.; D.Paola, M., 2012:
G11Tractography of the corpus callosum in Huntington disease

Mochel, F.; N., T.M.; Deelchand, D.; R., D.; V., R.; W., C.; C., P.; D., A.; H., P.G., 2012:
G13Abnormal responses to visual cortex activation in early stage Huntington disease patients using 31P-Nmr spectroscopy

Wolf, R.; Groen, G.; S., F.; V., N.; W., N.; Thomann, P.; Saft, C.; L., G.; Orth, M., 2012:
G14Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness

Matusch, A.; S., C.; E., D.; K., P.; Gold, R.; H., H.P.; Bauer, A., 2012:
G15Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease: a Pet study

Paulsen, J.; Long, J.; Kim, J.; Mills, J., 2012:
H01Prospective diagnosis of huntington disease: prognostic indicators and directions for future study

Warner, J., 2012:
H02Progress report for the model-Hd project (follow-up on Ehdn announcement)

Paulsen, J.; Long, J., 2012:
H03Rate of progression is associated with age of disease onset for all Hd

Gaus, W.; E., B., 2012:
H04Prognostic factors for the speed of progression of Hd results of a re-evaluation of the riluzole study

Cavanna, A.E.; Pilcher, F., 2012:
P5 Initial treatment retention to habit reversal training in Tourette syndrome

Clempson, A.; Dobson, S.; Stern, J.S., 2012:
P7 Dentists treating Tourette syndrome

Ali, K.; J., Y.; H., S.; W., M., 2012 :
Reversible Cerebral Vasoconstriction Syndrome As A Cause Of Subarachnoid Haemorrhage

Seemungal, B.; G.-Lopez, J.; A., Q.; S., S.; Walsh, V.; Y., N., 2012:
Vestibular Activation Differentially Modulates Human Early Visual Cortex And V5/Mt Excitability And Response Entropy

Shakespeare, T.; C., S., 2012:
Eye Tracking In Posterior Cortical Atrophy: A New Insight Into The Visual Syndrome

Wong, S.; Silva, F.; H., M.; A., J.; Plant, G., 2012:
An Old Friend Revisits: Chloramphenicol Optic Neuropathy

Wong, S.; C., G.; G., E.; Plant, G., 2012:
Blindness Cured!: Response To Late Steroids In Crion

Anderson, J.; R., N.; Smith, P., 2012:
Promoting Feedback In Clinical Neuroscience Teaching

Hinze, S.; Loo, S., 2012:
Perceptions Of Learning And Teaching In Postgraduate Neurology Training

Sharaf, N.; S., S., 2012:
A 9-Year Retrospective Study On Cavernous Sinus Syndrome

Maw, K.; J., J.; Llewelyn, J., 2012:
Acute Neurology Service Provision At A District General Hospital

Maxwell, G.; J., J.; A., N.; B., D., 2012:
Acute Neurology In The District General Hospital: The Role Of The Acute Neurologist

Panicker, J.; L., A., 2012:
Two-Week Wait Referrals For Cns Cancer-Are They Working?

Phizacklea, J.; K., S.; K., K.; D., G.; C., M., 2012:
Student Led Development And Evaluation Of Undergraduate Neurology Virtual Patient E-Learning Modules

Arthur-Farraj, P.; M., S.; L., M.; L., M.; Manji, H.; B., J.; R., G.; F., Z.; R., M., 2012:
Hand Weakness In Charcot-Marie-Tooth Disease 1X

Crawley, F.; S., I.; B., S., 2012:
Death In Mnd, Experience In The East Of England

Michael, B.; M.-McNulty, P.; M., N.; F., N.; Crooks, D., 2012:
Improving The Diagnosis Of Leptomeningeal Malignancy Through An Intervention To Optimise Cerebrospinal Fluid Collection

Rafiq, M.; P., A.; McDermott, C.; Shaw, P., 2012:
Clinical Evaluation Of Transcutaneous Carbon Dioxide Monitor (Tosca) In Patients With Motor Neurone Disease

Winston, J.; R., R.; Davie, C.; L., N.; S., R., 2012:
Changes In Workload And Case Mix In A London Hyperacute Stroke Unit Over Time

Scotton, W.; Scott, K.; Almedom, L.; W., L.; Janssen, A.; N., C.; S., M.; L., P.; Shaw, C.; A.-Chalabi, A., 2012:
Prognostic Categories For Amyotrophic Lateral Sclerosis

Brown, J.; R., S.; C., K.; D., H.; I., F.; C., P.; W., J., 2012:
Test Your Memory (Tym) Testing In Non-Alzheimer Dementias

Crutch, S.; L., M.; W., E.; Warren, J.; Rohrer, J., 2012:
Parietal Contributions To Language Processing: Progressive Aphasia In Posterior Cortical Atrophy

Haider, S.; Landwehrmeyer, B.; Sissumuth, S.; Frost, C.; F., R.; A., R.; C., A.; C., D.; Westerberg, G.; T., S.J., 2012:
From Biology To The Bedside-Sirtuins As Targets For Disease Modification In Huntington'S Disease: Selisistat Preclinical Data And Preliminary Phase I Results

Webb, A.; S., M.; R., P., 2012:
Increased Middle Cerebral Artery Pulsatility In Patients With Leukoaraiosis: Enhanced Transmission Of Aortic Pulse Waves Due To Increased Arterial Stiffness

Dobson, R.; R., R.; Giovannoni, G., 2012:
Can We Reliably Use Mri To Monitor Treatment Response In Patients On Interferon : A Systematic Review And Meta-Analysis

Zhang, L.; B., P.; M., A., 2012:
Mri Findings In Acute Wernicke'S Encephalopathy

Honarbakhsh, S.; O., C.; T., J.; G., C., 2012:
Ultrasound-Guided Lumbar Puncture As A Diagnostic Aid To Improve Patient Safety And Satisfaction: Desirable Or Necessary?

Hughes, S.; Spelman, T.; G., O.; Boz, C.; T., M.; M.Donnell, G.; Hawkins, S.; Kee, F.; B., H., 2012:
Predictors Of Postpartum Relapses In Women With Multiple Sclerosis: Results From The Msbase Registry

Zajicek, J.; H., J.; W., D.; B., S.; N., A.; V., J., 2012:
Results From The Cannabinnoid Use In Progressive Inflammatory Brain Disease (Cupid) Trial

Lilleker, J.; M., R., 2012:
Voltage-Gated Potassium Channel (Vgkc) Antibodies In Epilepsy: Diagnostic Yield And Therapeutic Implications

Saha, R.; H., S.; C., A., 2012:
A Prospective Case Control Study Of The Use Of A Virtual Neurology Clinic In An Urban Uk Setting

Mougin, O.; Mistry, N.; P., M.; Gowland, P.; E., N.; S., K., 2012:
Multi-Modal Mri At 7T To Detect And Quantify Multiple Sclerosis Cortical Grey Matter Pathology

Lacey, A.; Smith, P.; Rees, M.; Thomas, R., 2012:
Sudep (Sudden Unexpected Death In Epilepsy) Following Status Epilepticus

Flores, L.; O., K.; Hanna, J.; Nashef, L., 2012:
Development And Pilot Of A Questionnaire For Reporting Epilepsy-Related Deaths

Paul, N.; R., P., 2012:
Why Do Motor Symptoms Predict A High Early Risk Of Stroke After Tia?

Paul, N.; Li, L.; R., P., 2012:
Potential Utility Of Face Arm Speech Test (Fast) In Public Education About Tia And Minor Stroke

Simoni, M.; L., L.; M., Z.; R., P., 2012:
Ten-Year Premorbid Blood Pressure Control And White Matter Changes In A Population-Based Cohort Of Tia And Stroke Patients

Mantoan, L.; M., M.; W.-Jones, M.; A.-Memar, A., 2012:
The Dangers Waiting To Pounce On Holiday

Jacob, P.; W., K.; W., B., 2012:
Educating Patients About Hypersensitivity Drug Reactions In The Epilepsy Clinic: Are We Doing Enough?

Moor, M.C.C., 2012:
T Nover Mutation In Hmbs Gene Presenting With Bathing Suit Sensory Impairment And Recurrent Neurological Deficit

Natalie, S.; W., D.; I., J., 2012:
Getting That Sinking Feeling. An Unusual Cause Of Dementia

Belessiotis, C.; F., A.; C., A., 2012:
Progressive Multifocal Leukoencephalopathy Presenting As Corticobasal Degeneration Syndrome In A Heart Transplant Recipient

Wieshmann, U.; Andrew, T.; Milinis, K.; Baker, G., 2012:
Self-Reported Adverse Effects Of Mono- And Polytherapy For Epilepsy

Abela, C.; Mclellan, L.; T., K.; J., O.; D., D.; B., J.; H., R.; J., B.; D., Z., 2012:
A 10Year Experience Of Over 100 Frontofacial Procedures In Syndromic Children And Their Complications

Fois, A.; Anderson, J.; Lennox, G., 2012:
Giant Cell Arteritis In Trigeminal Autonomic Cephalgia

McLauchlan, D.; R., M.; D., N., 2012:
Sunct: A Novel Therapeutic Approach

Hall, M.; B., J.; P., O.; B., P.; R., R., 2012:
The Role Of The Inferior Colliculus In Auditory Temporal Resolution And Categorical Speech Perception

Ellul, M.; S., S.; C., A.; Zandi, M., 2012:
Two Interesting Cases Of Nmdar Encephalitis And A Typical But Seronegative Case With Ovarian Teratoma

Burns, H.; R., P.; A., A.Y., 2012:
An Unpleasant Hit From Cocaine: A Case Of Cocaine-Induced Cerebral Venous Sinus Thrombosis

McColgan, P.; McCarthy, C.; Martin, P., 2012:
A Case Of Acute Cerebellar Ataxia Due To Epstein-Barr Virus And Review Of The Literature

Wickremaratchi, M.; C., R.; Stern, W.; H., R.; W., M.; Vincent, A., 2012:
Glycine Receptor Antibody Mediated Progressive Encephalomyelitis With Rigidity And Myoclonus (Perm) Presenting With Respiratory Compromise In A 40-Year-Old Male

Cheripelli, B.; H., G., 2012:
A Case Of Delayed Diagnosis Of Severe B. Burgdorferi Meningo-Encephalitis

Kousin-Ezewu, O.; Y., M.; Macdonald, B.; O'Connell, ,S.O.C., 2012:
Lyme Disease Masquerading As An Optic Neuritis

Nightingale, S.; S., T., 2012:
Penetration Of Antiretroviral Therapy Into The Nervous System; Cognitive Impairment In Hiv And The Role Of The Cns As A Sanctuary Site. A Progress Report On The Partition Study

Turnbull, H.; P., A., 2012:
A Study In Yellow: The Case Of The Hidden Hyphae

Sharma, K.; W., D.; B., L., 2012:
Confusion In The Returned Traveller A Rare Cause Of Encephalitis

Burke, A.; M., E.; B., K.; Veneziano, L.; G., P., 2012:
Novel De Novo Mutation Causing Benign Hereditary Chorea With Hypothryoidism And A Pituitary Mass

Cameron Smail, R.; M.Colgan, P.; P., R., 2012:
Parkinson'S Disease Get It On Time Audit

Galtrey, C.; K., J.; C., A.; M., M., 2012:
Changing Phenotype Of Familial Paroxysmal Kinesigenic Dystonia Related To Oxcarbazepine Treatment

Hicks, S.; Scahill, R.; Dumas, E.; Durr, A.; Blair, R.; Levitt, B.; Roos, R.; Tabrizi, S.; Kennard, C., 2012:
Oculomotor Deficits In Premanifest And Early Huntington'S Disease And Their Structural Brain Correlates: The Longitudinal Track-Hd Study

Marion, M.; Kyei, G., 2012:
A Case Series Of Craniofacial Hyperhydrosis: Clinical Characteristics And Treatment With Botulinum Toxin

McAuley, J.; G., S., 2012:
Olfactory Hallucinations In Idiopathic Parkinson'S Disease

O'Brien, M.; K., K.; R., M.; S., B.; W., C.; H., M., 2012:
Wilson'S Disease In Ireland: Increasing Prevalence Over 40Years

George, J.; D., C.; H., S.; K., C.; E., J., 2012:
Opt Without Pt?

Rajakulendran, S.; S., H.; K., M.; H., M., 2012:
Deletion Of The Potassium Channel Gene Kcnc2 In A Family With Neurodevelopmental Delay And Ataxia

Salter, E.; Z., M.; Alexander, S.; Hanemann, C.; Zajicek, J.; Carroll, C., 2012:
Endocannabinoid Toxicity In A Cell Culture Model Of Parkinson'S Disease

Papachatzaki, M.; Ali, N.; P., Y.; C., S.; E., C.; S., K., 2012:
A New Phenotype Of Papt: Progressive Ataxia, Palatal Tremor And Optic Atrophy

Sleeman, K.; H., Y.; Verne, J.; G., M.; S., E.; G., W.; H., I., 2012:
Trends In Place Of Death, And The Effect Of Death Certificate Classification And Coding Changes, In Parkinsons Disease, Motor Neurone Disease, And Multiple Sclerosis In England: 19932010

Smith, M.; Hofereiter, J.; S., J.; P., J., 2012:
Nocturnal Polyuria In Parkinson'S Disease Patients Presenting With Nocturia

Williamson, J.; F., B.; C., J.; M., S.; D., A.; B., B.; E., M.; P., S.; R., A., 2012 :
A Patient With Chorea-Acanthocytosis And Dilated Cardiomyopathy

Alexander, S.; Acosta-Cabronero, J.; P., G.; D.-Grenu, L.; N., P., 2012:
Beyond The Hippocampus: Memory Impairment In Ad Might Also Relate To Retrosplenial Damage

Blackburn, D.; A., J.; Bandmann, O., 2012:
A Night To Remember: All White Then, All Right Now?

Cameron Smail, R.; T., H.; M. Siddiqi, S.; S., S.; M.Colgan, P., 2012:
A Case Of Toxic Cystic Leukoencephalopathy After Anti-Psychotic Overdose

Elsone, L.; M., K.; T., T.; B., M.; N., T.; J., A., 2012:
Neurogenic Pruritus In Neuromyelitis Optica

George, J.; K., J.; L., M.; Elston, J.; Matthews, B.; Cortes, N.; D., M.; J., N.; P., J., 2012:
Neuromyelitis Optica Spectrum Disorder And Cmv Retinitis: A Case Report

Murdoch, M.; Kirrane, K.; Shivane, A.; Fewings, P.; Perriss, R.; Salih, I.; Imam, I., 2012:
Primary Angiitis Of The Central Nervous System: Deceptive Presentation Of A Rare Disease

Iqbal, A.; B., D.; R., M.; S., B., 2012:
Multiple Cranial Nerve Palsies In A Young Singer

Kelly, S.; D., M.; B., L.; K., K.; M.Guigan, C.; H., M.; T., N., 2012:
The Cost Of A Multiple Sclerosis Relapse

Osman, C.; W., F.; Dangri, P.; H., O., 2012:
Mistaken Tetany: Hypoparathyroidism In The Tia Clinic

Kitley, J.; E., L.; G., J.; J., A.; L., M.; Palace, J., 2012:
Methotrexate May Be An Alternative To Azathioprine In Neuromyelitis Optica With Aquaporin-4 Antibodies

Raffel, J.; H., D.; T., J.; B., J.; G., G., 2012:
Classification Of Jc Virus Serostatus Depends Upon Assay Selection: A Comparison Of Biogen And Hpa Assays

Lonergan, R.; K., K.; F., P.; D., M.; J., S.; B., D.; H., M.; T., N., 2012:
Factors Relating To Unmet Needs Of Irish Ms Patients

Sharma, K.; C., D.; Inglis, K.; R., S., 2012:
Does Natalizumab Treatment Increase The Risk Of Herpes Simplex Encephalitis In Multiple Sclerosis? Case And Discussion

Turnbull, H.; K., N.; H., F.; P., A., 2012:
A Case Of Relapsing-Remitting Tumefactive Multiple Sclerosis

Warner, G.; Benjamin, J.; M.Kinnon, A., 2012:
Mri Brain Appearances In Anaphylaxis: Novel Observations To Differentiate From Global Hypoxic Insult

Pickrell, O.; W., B.; Walters, R., 2012:
Thoracic Spinal Cord Herniation Following Spontaneous Intracranial Hypotension And Subdural Haematoma: A Case Report

Zhang, L.; P., D.; Khan, U., 2012:
Cerebrovascular Events Unmasking A Rare But Treatable Disease

Akhtar, N.; S., L.; S., N., 2012:
Diagnostic Yield Of Sural Nerve Biopsy, A Retrospective Analysis Of 10Years Data

Chhetri, S.; P., E.; C., P.; G., J.; A.-Jones, R.; M., T., 2012:
Percutaneous Endoscopic Gastrostomy (Peg) In Mnd: A 10-Year Experience

Chinnery, P.; P., G.; G., H.; E., H.; B., R.; S., V.; U., B.; H., R.; D., D., 2012:
Exome Sequencing In Three Families With Cytoplasmic Body Myopathy With Early Respiratory Failure

Damodaran, D.; Varma, A., 2012:
Meningo-Encephalitis With Neuropathy; Bickerstaff/Fisher Syndrome An Under Recognised Entity

Jaffer, F.; Reilly, M.; Quinlivan, R.; Muntoni, F.; Orrell, R.; Wraige, E.; Saha, R.; Radunovic, A.; Mummery, C.; Parton, M.; Hanna, M., 2012:
Avoiding Unplanned Hospital Admissions In Patients With Neuromuscular Diseases: A Regional Collaborative Audit Of Hospital Admissions

Peukert, T.; H., S., 2012:
A Sticky Case Of Neuropathy

Vijayarangam Shanmugam, S.; R., Y., 2012:
A Rare Form Of Brachial Neuritis

Williamson, J.; M., C., 2012:
Relapsing Lymphadenitis And Lower Limb Weakness; A Diagnosis Of Kikuchi-Fujimoto Disease

Garcia-Reitboeck, P.; M.Donald, M.; T., G.; O., S.; G., C., 2012:
Anti-Ma2 Antibodies In A Patient With Upbeat Nystagmus

Gutowski, N.; R., S.; W., J., 2012:
Lung Tumour Secreted Vegf And Tnf- Induce Expression Of Adhesion Molecules On Cerebral Endothelial Cells

Williams, J.; O'Connell, K.; K., J.; C., T.; C., A.; M.Guigan, C., 2012:
A Lump In The Throat

Hofereiter, A.; S., M.; S., J.; F., Z.; M., E.; E., A.; L., R.; P., J., 2012:
J Do Female Carriers Of The Abcd1 Gene For X-Linked Adrenoleukodystrophy Manifest With Urinary Symptoms?

Jindahra, P.; B., W.; P., A.; B., J.; Plant, G., 2012:
The Pupil Light Refex In Acquired Homonymous Hemianopia

Newby, R.; Lewis, M., 2012:
Convergence Spasm: A Novel Diagnostic Tool

McGonigal, A.; Bartolomei, F.; Gavaret, M.; Chauvel, P.; Regis, J., 2013:
Gamma Knife Radiosurgical Treatment Of Motor Cortex Epilepsy

Whitehorn, S.; Mohanraj, R.; Jones, M., 2013:
Superficial Siderosis Of The Central Nervous System: A Clinical Service Review

Jumma, O., 2013:
Posterior Reversible Encephalopathy Syndrome Secondary To Peritonitis

Vattakatuchery, J.; Lathif, N.; Joy, J.; Cavanna, A.; Rickards, H., 2014:
Pharmacological Interventions For Depression In People With Traumatic Brain Injury: Systematic Review

Lawson, R.P.; Nord, C.L.; Seymour, B.; Thomas, D.L.; Dolan, R.J.; Dayan, P.; Weiskopf, N.; Roiser, J.P., 2014:
Habenula Responses During Appetitive And Aversive Conditioning In Major Depressive Disorder

Phillips, O.; Caltagirone, C.; Squitieri, F.; Sabatini, U.; DiPaola, M., 2014:
E09 Iron Content In The Corpus Callosum In Huntington's Disease

Gregory, S.; Scahill, R.; Stopford, C.; Orth, M.; Durr, A.; Leavitt, B.; Roos, R.; Langbehn, D.; Johnson, H.; Rees, G.; Tabrizi, S.; Craufurd, D., 2014:
E16 Diffusion Tensor Imaging And Neuropsychiatric Disturbance In Huntington 's Disease

Seliverstov, Y.; Seliverstova, E.; Prikhodko, D.; Klyushnikov, S.; Konovalov, R.; Krotenkova, M.; Illarioshkin, S., 2014:
E21 Resting-state Functional Mri: Studying Default Mode Network In Healthy Controls Versus Early Manifest Patients With Huntington's Disease

Ruiz, J., 2014:
A13 Attention Model In Huntington Disease

Haider, S.; Raftopoulos, R.; Kapoor, R.; Tabrizi, S., 2014:
E29 Macular Volume Loss In Huntington's Disease On Optical Coherence Tomography- A Pilot Biomarker Study

Vaportzis, E.; Georgiou-Karistianis, N.; Churchyard, A.; Stout, J., 2014:
G03 The Type Of Concurrent Task Affects Dual-task Performance In Huntington's Disease

DeSouza, J.; Gordon-Smith, K.; Jones, L.; Rickards, H., 2014:
H09 The Depression Phenotype In Huntington's Disease

Dale, M.; Cramp, R.; Shimozaki, S., 2014:
H12 Anxiety And Depression In Huntington's Disease Across Disease Stage: Data From The Hospital Anxiety And Depression Scale (hads) Used In The Registry 3 Study

Perez-Perez, J.; Martinez-Horta, S.; Carceller, M.; Pagonabarraga, J.; de Bobadilla, R.; Campolongo, A.; Kulisevsky, J., 2014:
H15 Prevalence And Phenomenology Of Psychotic Symptoms In Huntington's Disease

Mariscal, N.; Cubo, E.; Rivadeneyra, J.; Armesto, D.; Mateos, A.; Camara, R.; Martinez, A., 2014:
I06 Dysphagia In Huntington`s Disease: A Multicenter Study

Gil Polo, C.; Delgado, E.; Cachorro, A.; Posadas, J.; Perez, N.; Formoso, D., 2014:
I09 Energy Balance In Huntington's Disease

Jones, U.; Busse, M.; Enright, S.; Rosser, A., 2014:
I11 Respiratory Function Decreases With Progression Of Huntington's Disease

Rodrigues, F.; Abreu, D.; Damasio, J.; Goncalves, N.; Correia-Guedes, L.; Coelho, M.; Ferreira, J., 2014:
I21 Causes Of Death In A European Huntington's Disease Cohort (registry)

Papoutsi, M.; Weiskopf, N.; Langbehn, D.; Reilmann, R.; Rees, G.; Tabrizi, S., 2014:
J02 Brain Training in Hd: Enhancing Neural Plasticity using Real-time Fmri Neurofeedback Training

Bates, G., 2014:
A19 Peripheral Pathologies in Mouse Models of Hd and the Inhibtion of Myostatin Signalling as a Possible Therapeutic Target

van Bruggen-Rufi, M.; Roos, R.; Achterberg, W.; Vink, A., 2014:
J11 Can Music Therapy Improve The Quality Of Life In Huntington's Disease?

Baine, F.; Kay, C.; Ketelaar, M.; Collins, J.; Krause, A.; Greenberg, L.; Hayden, M., 2014:
J38 Disease-associated Htt Haplotypes In The South African Population

Salvatore, E.; DiMaio, L.; Peluso, S.; Russo, C.; Sorrentino, P.; Massarelli, M.; Roca, A.; Iasevoli, F.; DeMichele, G., 2014:
K03 Ethical Issues In The Clinical Diagnosis Of Huntington Disease

Moser, K., 2014:
L25 The Role Of Occupational Therapy In The Care Of Individuals With Huntington's Disease

Brandt, M.; Nieuwkamp, M.; Kerkdijk, E.; Verschuur, E., 2014:
L28 Huntington Speech Music Therapy. A Therapy Based On The Principles Of The Speech Music Therapy For Aphasia, Adjusted For Patients With Huntington

Datson, N.; Mulders, S.; van de Giessen, J.; Gonzalez, A.; van Deutekom, J., 2014:
M02 Therapeutic Benefit Of A Htt-lowering Antisense Oligonucleotide Targeting The Cag-repeat In The R6/2 Huntington's Disease Mouse Model

Marelli, C.; Bonneaud, N.; Paucard, A.; Maschat, F., 2014:
M10 Efficacy of the Peptide P42B in Hela Cells and in the Hd Drosophila Model

Jones, L.; Gusella, J.; MacDonald, M.; Wheeler, V.; Lee, J.-M.; Myers, R.; Latourelle, J.; Jones, L.; Harold, D.; Holmans, P.; Orth, M.; Kwak, S., 2014:
A03 Genetic Modifiers Affecting The Age At Motor Onset In Huntington's Disease

Lejeune, F.; Parmentier, F.; Gilbert, F.; Neri, C., 2014:
B02 Systems Modelling And Network-based Approaches For Basic And Translational Research In Huntington's Disease

Szepesi, Z.; Li, W.; Li, J., 2014:
B20 Postsynaptic Density Protein-95 Influences Dendritic Spine Dynamics of Cortical Neurons in a Mouse Model of Huntington's Disease

Betuing, S.; Planques, A.; Moumne, L.; Lamazieres, A.; Boussicault, L.; Pages, C.; Aubourg, P.; Cartier, N.; Caboche, J., 2014:
B25 Beneficial Effects Of Striatal Restoration Of Cyp46a1 Expression On Cholesterol Metabolism And Neurodegeneration In Huntington's Disease Mouse Model (r6/2)

Hansikova, H.; Rodinova, M.; Spa ilova, J.; Kratochvilova, H.; Sladkova, J.; Markova, M.; Ma akova, M.; Bohuslavova, B.; Ellederova, Z.; Juhasova, J.; Li kova, I.; Klempir, J.; Roth, J.; Motlik, J.; Zeman, J., 2014:
B33 Non-neural Mitochondrial Impairment In Huntington's Disease Patients And Minipigs Transgenic For The N-terminal Part Of Human Mutated Huntingtin

Krzyszto -Russjan, J.; Sitarz, K.; Anuszewska, E., 2014:
B36 The In Vitrocell Culture Model Optimisation For Study Of Energy Metabolism In Huntington'S Disease

Laroche, M.; Demers, M.; Lessard-Beaudoin, M.; Garcia-Miralles, M.; Kreidy, C.; Franciosi, S.; Hayden, M.; Pouladi, M.; Graham, R., 2014:
B42 Huntington Disease and Olfactory Dysfunction: Structural Abnormalities of the Olfactory System and Early Caspase Activation in the Olfactory Bulb are Observed in Hd Mouse Models

Wirsig, M.; Schuldenzucker, V.; Schramke, S.; Frank, F.; Schubert, R.; Ott, S.; Marcegaglia, M.; Holzner, E.; Reilmann, R., 2014:
C17 Track Tghd Minipig - Startbox back and Forth Test

Ridsdale, L.; Noble, A.; Nadeem, F.; Morgan, M., 2014:
Patients' Ideas And Choices About The Management Of Headache

Lad, M.; Smith, M.; Seth, J.; Fowler, C.; Miller, R.; Panicker, J., 2014:
A Curious Case Of Urinary Retention

Porter, M.-C.; DeVita, E.; Simpson, I.; Franko, E.; Bjurstrom, N.; Rudge, P.; Mead, S.; Collinge, J.; Thornton, J.; Hyare, H., 2014:
Multi-Parameter Mri Analysis In The National Prion Cohort

Bhandari, N., 2015:
Serotonergic Drugs For Management Of Behavioural Symptoms Of Frontotemporal Dementia: A Systematic Review

Elian, M., 2015:
Why Do People Record Their Criminal Activity?

Goldstein, L.; Chalder, T.; C., A.; Landau, S.; M.Crone, P.; M., N.; M., N.; M., J.; R., M.; R., M.; S., J.; M., J., 2015:
Cognitive Behavioural Therapy Vs Standardised Medical Care For Adults With Dissociative Non-Epileptic Seizures (Codes): An Rct Protocol

Pope, R.A.; Thompson, P.J.; Rantell, K.; Stretton, J.; Wright, M.A.; Foong, J., 2015:
Predicting Psychiatric Outcome Following Temporal Lobe Epilepsy Surgery: A Longitudinal Study

McNulty, R.; Stern, J.; Simmons, H.; R., M., 2015:
Selection Of Treatment Targets For Patients With Tourette Syndrome

Whitehead, K.; Stone, J.; Norman, P.; Sharpe, M.; Reuber, M., 2015:
Differences In Relatives' And Patients' Illness Perceptions In Functional Neurological Symptom Disorders Compared To Neurological Disease

Paddick, S.; Gray, W.; Dotchin, C.; K., A.; M., G.; K., J.; M., S.; L., F.; M., D.; T., A.; O., A.; W., R., 2015:
Validation Of The Idea Cognitive Screening Tool For Older Adults In Hospital Inpatient, Outpatient And Rural Community Settings In Tanzania

Paddick, S.M.; Gray, W.; Dotchin, C.; K., A.; M., G.; K., J.; L., F.; M., S.; M., D.; T., A.; O., A.; W., R., 2015:
Prevalence Of Delirium In Older Hospitalised Adults In Tanzania. The Idea (Identification And Interventions For Dementia In Elderly Africans) Study

Martins, S.; Stern, J.; Simmons, H., 2015:
A Case Of Synaesthetic Tourette Syndrome

Nair, R.; R., P.; K., K., 2015:
The Great Imitator

Zouraraki, C.; Karagiannopoulou, L.; Karamaouna, P.; Tsapakis, E.-M.; Kopsahili, I.; Bitsios, P.; Giakoumaki, S., 2015:
Differential Association Of Schizotypal Traits With Strategy Formation, General Psychopathology And Quality Of Life In The Schizophrenia Spectrum: Findings From The Premes Study

Radakovic, R.; Stephenson, L.; Chandran, S.; Swingler, R.; Starr, J.M.; Abrahams, S., 2015:
Exploring The Dimensions Of Apathy In Als: Validation Of The Das

Novakova, B.; Harris, P.; Ponnusamy, A.; Marques, J.; Reuber, M., 2015:
Stress And Seizures: Exploring The Patterns Of Cognitive, Self-Perceived And Physiological Stress Responses In Patients With Epilepsy And Psychogenic Non-Epileptic Seizures

Fitzsimmons, S.; Jones, L.; Holmans, P., 2015:
Factors Influencing The Presence Of Behavioural Symptoms In Huntington'S Disease

Ross, A.; Rickards, H., 2015:
The Experiences Of Diagnosis For Adults With Tourette Syndrome

Palmer, E.; Stern, J., 2015:
Employment In Tourette Syndrome

Omar, A.; Stern, J.; Simmons, H.; R., M., 2015:
Motor Versus Vocal Tics

Nicholson, T.R.; Aybek, S.; O'Daly, O.; Zelaya, F.; Kanaan, R.A.; David, A.S., 2015:
Emotion-Motion Interactions In Conversion Disorder: An Fmri Study

Maguire, M.J.; Weston, J.; Singh, J.; Marson, A.G., 2015:
Antidepressants For People With Epilepsy And Depression

Guillochon, R.; Dilley, M., 2015:
Development Of Obsessive Compulsive Disorder (Ocd) Secondary To Traumatic Brain InjuryReview Of Literature And Comparison With Sample Of Patients From Lishman Unit, Maudsley Hospital

Dharia, S.; Zeman, A.; Devon, R., 2015:
Sleep-Deprivation Amnesia

Iddon, J., 2015:
A Three Dimensional Neuro-Cbt Model For Mild-Moderate Brain Injury

Eddy, C.M.; Martino, D.; Cavanna, A.E., 2015:
Perspective Taking And Personal Distress In Tourette Syndrome

Fisher, I.H.; Pall, H.S.; Mitchell, R.D.; Kausar, J.; Cavanna, A.E., 2015:
Subthalamic Nucleus Deep Brain Stimulation And Apathy In Patients With Parkinson'S Disease

Silva, B.; Barahona-Cornea, B.; Barreira, J., 2015:
Pre-Surgical Neuropsychiatric Evaluation In Epilepsy Surgery

Srirathan, H.; Cavanna, A.E., 2015:
Research Trends In Neuropsychiatry In The New Millennium

Liew, A., 2015:
An Audit Of The Management Of Epilepsy In Children And Young People With Intellectual Disabilities

Barahona-Correa, B.; Ribeiro, R., 2015:
The Neuroanatomy Of Secondary Bipolar Disorder

Mitchell, S.; Gao, J.; Hallett, M.; Voon, V., 2015:
The Role Of Novelty In Risk SeekingBehaviour

Baek, K.; Morris, L.; Voon, V., 2015:
Disrupted Complex Brain Network Properties In Obese Subjects

Morris, L.S.; Kundu, P.; Baek, K.; Irvine, M.A.; Mechelmans, D.J.; Wood, J.; Harrison, N.A.; Robbins, T.W.; Bullmore, E.T.; Voon, V., 2015:
Neural Correlates Of Waiting Impulsivity: A Dimensional Approach To Alcohol Misuse

Banca, P.; Vestergaard, M.D.; Rankov, V.; Baek, K.; Mitchell, S.; Lapa, T.; Castelo-Branco, M.; Voon, V., 2015:
Cautious Decision Making In Obsessivecompulsive Disorder: The Role Of Perceptual Uncertainty And Implicit Incentives

Demartini, B.; Ricciardi, L.; Parees, I.; Ganos, C.; Bhatia, K.P.; Edwards, M.J., 2015:
A Positive Diagnosis Of Functional (Psychogenic) Tics

Dewer, B.; Rogers, P.; Ricketts, J.; Mukonoweshuro, W.; Zeman, A., 2015:
Diagnosing Frontotemporal Dementia In Outpatients: An Audit Of Radiological Reports And Review Of Diagnostic Criteria

Pick, S.; Mellers, J.D.C.; Goldstein, L.H., 2015:
Misinterpretation Of Emotional Facial Expressions In Patients Diagnosed With Dissociative Seizures: Experimental Evidence

Lucia, R.; Benedetta, D.; Francesca, M.; Isabel, P.; Glenn, N.; Mark, E., 2015:
Symptom Severity In Patients With Functional (Psychogenic) Movement Symptoms: Patient'S Perception And Doctor'S Clinical Assessment

Arthuis, M.; M.-Franchi, J.; Bartolomei, F.; M.Gonigal, A.; G., E., 2015:
Resting Cortical Pet Metabolic Changes In Psychogenic Non-Epileptic Seizures (Pnes)

Wiseman, H.; B., R.; H., A.; H., S.; R., M., 2015:
A Brief Psycho-Education Intervention For Patients With Non-Epileptic Attack Disorder (Nead)

Koeda, M.; Watanabe, A.; Tsuda, K.; Matsumoto, M.; Ikeda, Y.; Kim, W.; Tateno, A.; Naing, B.T.; Karibe, H.; Shimada, T.; Suzuki, H.; Matsuura, M.; Okubo, Y., 2015:
Effect Of Cntnap2 Polymorphisms On Cerebral Response To Human Voice Perception And Handedness: An Fmri Study

Macerollo, A.; C., J.; Parees, I.; K., P.; K., J.; E., M., 2015:
Sensory Attenuation Assessed By Sensory Evoked Potentials In Functional Movement Disorders

Appleton, J.; Ilinca, A.; L., A.; Puschmann, A.; H., M.; S., K.; D.Silva, R.; J., M.; B., R.; N., D., 2015:
The Tos2 Study: An International Multi-Centre Audit Assessing The Standard Of Neurological Examination

Wong, S.; Petrie, A.; Plant, G., 2015 :
Ocular Mg In 101 Cases: Towards A Risk Of Generalisation (Rog) Score

Albor, C.; Sautoy, T.du; Vanan, N.K.; Boomla, K.; Schmierer, K., 2015:
Ethnicity And Multiple Sclerosis Prevalence In East London

Bashford, J.; Silber, E., 2015:
A Local Survey Amongst 92 Patients With Multiple Sclerosis: What Can We Learn About This Population'S Disease Management? How Satisfied Are Patients With Our Service?

Nicholas, R.; Berry, R., 2015:
Reduced Ms Relapse Rates With Natalizumab: Top Uk Cohort

Binks, S.; Green, L., 2015:
The Profile Of Multiple Sclerosis In General Practice

Campbell, J.; Cercignani, M.; Langdon, D.; Rashid, W., 2015:
Cognitive Rehabilitation In Multiple Sclerosis

Chataway, J.; Chandran, S.; Miller, D.; Giovannoni, G.; Wheeler-Kingshott, C.; Pavitt, S.; Stallard, N.; Hawkins, C.; Sharrack, B., 2015:
The Ms-Smart Trial In Secondary Progressive Multiple Sclerosis: A Multi-Arm, Multi-Centre Trial Of Neuroprotection

Coles, A.; Giovannoni, G.; Moreau, T.; Havrdova, E.; Margolin, D.; Kasten, L.; Singer, B., 2015:
Alemtuzumab Improves 3-Year Quality Of Life In Care-Ms Ii

Downham, C.; Visser, E.; Vickers, M.; Counsell, C., 2015:
Season Of Glandular Fever As A Risk Factor For Multiple Sclerosis

Doshi, A.; Voysey, Z.; Bunting, E.; Malik, M.; Rashid, W., 2015:
Regional Efficacy Of Natalizumab Treatment In Relapsing-Remitting Multiple Sclerosis (Rrms)

Healy, S.; W., M.; Pickersgill, T.; Page, M.; R., N., 2015:
Thyrotoxicosis Secondary To Alemtuzumab Treatment For Multiple Sclerosis Presenting As Pulmonary Hypertension

Rayan, D.R.; Horga, A.; Matthews, E.; Sud, R.; McCall, S.; Hanna, M., 2015:
Paramyotonia Congenita & Sodium Channel Myotonia: Are They Distinct Diseases?

McCarthy, C.; Tuohy, O.; Azzopardi, L.; Kousin-Ezewu, O.; Jones, J.; Compston, A.; Coles, A., 2015:
Long-Term Safety Of Alemtuzumab In Relapsing-Remitting Multiple Sclerosis: Pregnancy And Infection Data From A Cohort Of Patients On Open Label Studies In Cambridge

Constantinescu, C.; S., N.D.; Kappos, L.; R., E.; Sprenger, T.; M., D.P.; Häring, D.; T., D., 2015:
Partial Independence Of Fingolimod Effect On Diffuse Vs. Focal Damage

Pamies, P.; W., B.; P., E., 2015:
Management Of Fingolimod First Dose Observation (Fdo) In The Uk

Silber, E.; R., E.; Barkhof, F.; G., R.; Z., Y.; C., L.; von Rosenstiel, P.; K., L., 2015:
Sustained Low Rate Brain Volume Loss In Long Term Fingolimod Treatment

Seth, J.; Haslam, C.; Gonzales, G.; Pakzad, M.; Vashisht, A.; Elneil, S.; Sahai, A.; Knowles, C.; Tucker, A.; Panicker, J., 2015:
Single Centre Randomised Pilot Study Of Two Regimens (30 Mins Daily Or 30 Mins Weekly For 12 Weeks) Of Transcutaneous Tibial Nerve Stimulation Using A Novel Device For Treating Multiple Sclerosis-Related Overactive Bladder Symptoms

Raffel, J.; Gafson, A.; Nicholas, R., 2015:
Anti-Jcv Titres Increase Over Time With Natalizumab Treatment

Raffel, J.; Gafson, A.; Dahdaleh, S.; Nicholas, R., 2015:
Early Prediction Of Long-Term Response To Natalizumab In Multiple Sclerosis

Sharrack, B.; Mayer, L.; Coles, A.; Hartung, H.-P.; Havrdova, E.; Selmaj, K.; Margolin, D.; Compston, A., 2015:
Management Of Adverse Reactions To Alemtuzumab Infusion

Ahmad, H.; Cerchiai, N.; Mancuso, M.; Casani, A.; Bronstein, A., 2015:
Are White Matter Abnormalities A Cause Of Unexplained Dizziness? A Retrospective BiCentre Study

Weller, B.; Comi, G.; Freedman, M.; Kappos, L.; Miller, A.; Olsson, T.; Wolinsky, J.; Benamor, M.; Truffinet, P.; O'Connor, P., 2015:
Effect Of Teriflunomide On Lymphocyte And Neutrophil Counts

Barnes, D.; Leist, T.; Freedman, M.; Olsson, T.; Miller, A.; Wolinsky, J.; O'Connor, P.; Benamor, M.; Truffinet, P.; Comi, G., 2015:
Safety And Tolerability Of Teriflunomide In Clinical Studies

Rog, D.; Wolinsky, J.; Truffinet, P.; Thangavelu, K.; Miller, A., 2015:
Analysis Of The Topic Study Using 2010 Mcdonald Criteria

Weerasinghe, K.C.; Shanmugarajah, P.; Russell, M.; Ford, H., 2015:
Early Relapses In Patients With Highly Active Multiple Sclerosis Commenced On Fingolimod; The Leeds Teaching Hospital Experience

Wicks, C.R.; Ward, K.; Stroud, A.; Tennant, A.; Ford, H., 2015:
Psychological Attributes And Work Instability In Ms

Williams, O.H.; Harding, K.E.; Willis, M.; Pickersgill, T.; Wardle, M.; Robertson, N.P., 2015:
Disease Modifying Treatment Utilisation In Multiple Sclerosis

Willis, M.; Cossburn, M.; Ingram, G.; Pickersgill, T.; Barry, S.; Robertson, N., 2015:
Hypersensitivity Pneumonitis Following Alemtuzumab Treatment For Multiple Sclerosis

Scolding, N.; Wang, H.; Liu, Y.; Steinman, L., 2015:
Patient-Reported Outcomes And Disability In Multiple Sclerosis

Al-Ansari, A.; Hill, M., 2015:
Case Report: A Presumptive Diagnosis Of Acute Disseminated Encephalomyelitis

King, D.; Appleton, J.P.; Jacob, S., 2015:
Susac'S Syndrome: A Case Series From A Regional Neurosciences Unit

Fletcher, P.; Rohrer, J.; Schott, J.; Rossor, M.; Warren, J., 2015:
Abnormal Pain And Temperature Processing In Dementia

Hamid, S.; Elsone, L.; Waters, P.; Woodhall, M.W.; Mutch, K.; Rafferty, C.; Tang, L.; Solomon, T.; Vincent, A.; Jacob, A., 2015:
Glycine Receptor AntibodyA Marker For Nmo/ Non-Ms Demyelination?

O'Sullivan, O.; Sturrock, A.; Jacob, S., 2015:
Hashimoto'S Encephalopathy Presenting As Refractory Hypothermia

Weerasinghe, S.; Sadalage, G.; Jacob, S., 2015:
A New Clinical Tool (Brit) To Monitor Ivig Efficacy In Patients With Stiff Person Syndrome

Sadalage, G.; Karim, A.; Jacob, S., 2015:
Clinical Features And Treatment Response In A Large Uk Cohort Of Stiff Person Syndrome Patients

Juryńczyk, M.; Weinshenker, B.; Wingerchuk, D.; Akman-Demir, G.; Asgari, N.; Barnes, D.; Boggild, M.; Chaudhuri, A.; Leite, I., 2015:
Expert Opinions On The Diagnosis And Treatment Of Patients With Aqp4-Negative Nmo/Ms Overlapping Syndromes

Matthews, R.; Hackett, R.; Jones, M., 2015 :
Psychiatric Presentations Of Autoantibody-Mediated Encephalitis

Mbizvo, G.; Ellis, R.; Michael, B.; Rathi, N.; D., M.; C., D., 2015:
Cerebral Vasculitis Histopathology In Relapsing Polychondritis

Appleton, J.P.; Hayton, T.; Williams, A., 2015:
Pilocytic Astrocytoma: A Case Of Not So Benign Intracranial Hypertension

Hrastelj, J.; Bryl, B.; Al-Bermani, A.; Corkill, R., 2015:
A Sight-Threatening Papilloedema Mimic: Polypoidal Choroidal Vasculopathy

Rudd, D.; Jaiser, S.; Bradshaw, K.; Archibald, N., 2015:
Going Blind On Dialysis: Nyctalopia Due To Tranexamic Acid

Keatinge, M.; DaCosta, M.; Menke, A.; Chen, Y.-C.; Bui, H.H.; O'Neill, M.; Bandmann, O., 2015:
Zebrafish As A Model Of Glucocerebrosidase 1 (Gba1) Deficiency

Kaski, D.; Bronstein, A.; Cutfield, N.; Buckwell, D.; Banga, R.; Ray, J.; Chavda, S.; Irving, R., 2015:
Head Jolting Nystagmus: Head-Shaking-Induced Occlusion Of The Horizontal Semicircular Canal

Carr, A.; Evans, M.; Pelayo-Negro, A.; Shah, S.; Choi, D.; Blake, J.; Phadke, R.; Gilmore, J.; Hawkins, P.; Reilly, M., 2015:
Spinal Stenosis In Familial Transthyretin Amyloidosis

Sadalage, G.; Ali, S.; Mocroft, P.; Williams, A.; Jacob, S., 2015:
Unusual Decremental Response In Lambert Eaton Myasthenic Syndrome

Lavin, T.; Al-Bachari, S.; Gosal, D.Y., 2015:
Clinical And Electrophysiological Characteristics Of 103 Patients With Sensory Neuronopathy

Maddison, P.; Ghosh, R., 2015:
An Audit Of Hospitalisation In Myasthenia Gravis Patients

O'Dowd, S.; Munteanu, T.; Hardiman, D.; Langan, Y.; Brett, F.; Redmond, J., 2015:
Ockham'S Razor Or Hickam'S Dictum? The Diagnostic Journey Of A Patient With Proximal Myopathy

Rafiq, M.; Proctor, A.; McDermott, C.; Shaw, P., 2015:
Screening For Respiratory Failure In Als Using Clinical Questioning, Respiratory Function Tests And Transcutaneous Carbon Dioxide: Which Is The Better Tool?

Wu, K.; Rigaudy, A.; Christodoulou, L.; Okello, A.; Ballard, E.; Hart, N.; Howard, R., 2015:
Analysis Of An Adult Duchenne Muscular Dystrophy Population: Ten Years On

Chen, Z.; Lin, K.; Shatunov, A.; Jones, A.; Al-Chalabi, A., 2015:
Gene Set Enrichment Analysis In Amyotrophic Lateral Sclerosis

Mistry, N.; Jacob, S., 2015:
Paraneoplastic Nmo And Review Of Mri Findings In 18 Nmo Patients

Carr, A.; D'Sa, S.; Arasaretnam, A.; B., K.; J., R.; J., Z.; Brandner, S.; Marafioti, T.; K., M.; Lunn, M., 2015:
Peripheral Nerve Bing-Neel Syndrome

Carr, A.; Jaunmuktane, Z.; Brandner, S.; Kothari, J.; B., J.; D'Sa, S.; Lunn, M., 2015:
The Neuropathy Spectrum In WaldenstrM'S Macroglobulinaemia

Datta, S.; Lee, R.; Webb, T.; Ismail, A.; Jung, A., 2015:
Years Experience Of Primary Central Nervous System Lymphoma (Pcnsl): A Retrospective Pilot Audit

Dharia, S.; Harrower, T., 2015 :
Cns Relapse Of Nhl Masquerading As Miller Fisher Syndrome

Gutowski, N.; R., S.; W., J., 2015:
Lung Cancer Brain Metastases: Factors Enhancing Tumour Cell Adhesion

Evans, W.; Carey, M.; Dunne, F.; Nagaraju, S.; Hayton, T., 2015:
Audit Of Csf Cytology At The West Midlands Neuroscience Centre

Kioulachidis, K.; Ailenei, E.; Afshari, F.; Mockova, M., 2015:
Rare Paraneoplastic Polyneuropathy Secondary To Skin Melanoma

Samani, A.; Davagnanam, I.; Cockerell, O.C.; Ramsay, A.; Patani, R.; Chataway, J., 2015:
Lymphomatosis Cerebri: A Treatable Cause Of Rapidly Progressive Dementia

Zienius, K.; Rooney, A.; Grant, R., 2015:
Levetiracetam Is Independently Associated With Fatigue In Adult Glioma Outpatients

Chen, Z.; Shatunov, A.; Bensimon, G.; Payan, C.; Ludolph, A.; Leigh, N.; Group, N.S.; Al-Chalabi, A., 2015:
A Genome-Wide Association Study In Progressive Supranuclear Palsy

Agrawal, A.; Zaidi, S.; R., B.; C., M., 2015:
A Case Of Enlarged Virchow Robin Spaces Causing Progressive Hemi Sensory Symptoms

Ahmad, H.; Roberts, R.; Arshad, Q.A.; Patel, M.; Bronstein, A., 2015:
Using Transcranial Magnetic Stimulation (Tms) To Probe Effects Of Visual Motion Adaptation On Primary Visual Cortex (V1) Excitability In Bilateral Vestibular Failure (Bvf) Patients

AlMasri, O.; Massey, T.; Mukhopadhyay, D.; Walters, R.J., 2015:
The Many Faces Of Melas

Chance, L.; Gray, O., 2015:
A Spastic Ataxic Gait With A Bit More Bite

Doshi, A.; Haque, A.; Chowdhury, M.; Boyd, K., 2015:
Bing-Neel Syndrome: A Rare Cause Of Progressive Gait Disturbance And Dementia

Hoeritzauer, I.; Stone, J.; Fowler, C.; Elneil, S.; Carson, A.; Panicker, J., 2015:
Fowler'S Syndrome Of Urinary Retention: A Retrospective Study Of Co-Morbidity

Jenkins, P.; Fleminger, J.; De-Simoni, S.; Jolly, A.; Gorgoraptis, N.; Hampshire, A.; Sharp, D., 2015:
Home Computerised Cognitive Testing For Tbi Is Feasible And Popular

Kapoor, A.; Chinthapalli, K.; Warner, G., 2015:
Bilateral Internal Carotid Artery Dissection With Confusion

Minks, E.; Jurák, P.; Chládek, J.; Hummelová, Z.; Halámek, J.; Minksová, A.; Bareš, M., 2015:
Are Subthalamicus Nucleus, Internal Globus Pallidus And Thalamus Involved In Thinking?

Al-Bachari, S.; Vidyasagar, R.; Silverdale, M.; Emsley, H.; Parkes, L., 2015:
Similarities In Arterial Arrival Time Prolongation And Posterior Hypoperfusion In Patients With Idiopathic Parkinson'S Disease And Stroke

Baig, F.; Lawton, M.; Rolinski, M.; Ruffmann, C.; Nithi, K.; Evetts, S.; Fernandes, H.; Ben-Shlomo, Y.; Hu, M., 2015:
Impact & Treatment Of Non-Motor Symptoms In Early Parkinson'S Disease

Cosgrove, J.; Jamieson, S.; Smith, S.; Alty, J., 2015:
Visuospatial Tests To Screen For Impaired Cognition In Parkinson'S

Cosgrove, J.; Jamieson, S.; Smith, S.; Alty, J., 2015:
The Relationship Between Clock Drawing And Cognition In Parkinson'S

Cosgrove, J.; Lacy, S.; Jamieson, S.; Smith, S.; Alty, J., 2015:
Finger Tapping And Cognition In Parkinson'S

Sleeman, I.; Che, Z.-C.; Counsell, C., 2015:
Fracture Risk In Incident Parkinsonian Cohort Versus Controls

Fearon, C.; Newman, L.; Quinlivan, B.; Butler, J.; Lynch, T.; Reilly, R., 2015:
Investigation Of Motor Learning In Parkinson'S Disease Using An Action Acquisition Task

Goddard, H.; Macleod, A.; Counsell, C., 2015:
Co-Morbidity Burden In Parkinson'S Disease And Matched Controls

Macleod, A.; Counsell, C., 2015:
Predictors Of Institutionalisation In Parkinson'S Disease

Macleod, A.; Counsell, C., 2015:
Mortality In Parkinson'S Disease And Atypical Parkinsonian Disorders

Macleod, A.; Counsell, C., 2015:
The Predictive Value Of Different Motor Features In Parkinson'S

Muhammed, K.; Manohar, S.; Tofaris, G.; Lennox, G.; Bogdanovic, M.; Hu, M.; Husain, M., 2015:
Reward Sensitivity Deficits Underlie Apathy In Parkinson'S Disease

Payne, T.; Keatinge, M.; Costa, M.D.; Bandmann, O., 2015:
Mpp+ In A Zebrafish Model Of Glucocerebrosidase 1 Deficiency

Rolinski, M.; Zokaei, N.; Lawton, M.; Evetts, S.; Mackay, C.; Quinnell, T.; Zaiwalla, Z.; Ben-Shlomo, Y.; Husain, M.; Hu, M., 2015:
Features In Idiopathic Rbd Mirror Those Observed In Pd

Rolinski, M.; Griffanti, L.; Szewczyk-Krolikowski, K.; Menke, R.; Quinnell, T.; Zaiwalla, Z.; Mackay, C.; Hu, M., 2015:
Neuroimaging Of Idiopathic Rem Sleep Behavior Disorder

Roussakis, A.-A.; Politis, M.; Towey, D.; Piccini, P., 2015:
Serotonin-To-Dopamine Transporter Ratios In The Striatum Of Patients With Parkinson'S Disease: Impact On LevodopaInduced Dyskinesias

Zaidi, S.; Agrawal, A.; Davey, R., 2015:
A Case Of Atraumatic Convexal Subarachnoid Haemorrhage Due To Unusual Cause

Dodd, K.; Pegg, E.; Mathur, S.; Suresh, C., 2015:
Thrombosed Brainstem Developmental Venous Anomaly Causing Hydrocephalus

Geranmayeh, F.; Wise, R., 2015:
Network Dysfunction In Post-Stroke Aphasia

McMacken, G.; McKenna, E.; McKee, S.; McConville, J., 2015:
Cadasil In Northern Ireland: A Retrospective Clinical, Neuroimaging And Genetic Study

Lavin, T.; McMinn, J.; Punter, M.; Kellett, M., 2015:
The Effect Of A New Policy For Inward Transfer Of Patients Diagnosed With Cerebral Venous Thrombosis (Cvt) Across Greater Manchester To The Tertiary Neurosciences Centre

Keitley, J.; Lavin, T.; Punter, M.; McMinn, J.; Kellett, M., 2015:
A Comparison Of Assessment, Diagnosis And Treatment Of Patients With Cerebral Venous Thrombosis Before And After Introduction Of A New Policy And Guideline Across Greater Manchester

Patel, B.; Nagendran, A.; Khan, U., 2015:
The Zebra Sign

Tan, R.; Markus, H., 2015:
Next Generation Sequencing In Familial Cerebral Small Vessel Disease - An Ongoing Study

Baheerathan, A.; Gananandan, K.; Swayne, O., 2015:
The Impact Of An Epilepsy-Care Bundle On The Management Of Acute Seizures In A Large London-Based District General Hospital

Kotecha, G.; Mano, H.; Leibnitz, K.; Nakae, A.; Voon, V.; Yoshida, W.; Yanagida, T.; Kawato, M.; Rosa, M.J.; Seymour, B., 2015:
A Neural Biomarker For Chronic Pain Based On Decoded Brain Networks

Li, L.; Leech, R.; Seemungal, B.; Malhotra, P.; Sharp, D., 2015:
A Sense Of Direction: Brain Stimulation In Lateralised Brain Function

Breen, D.; Vuono, R.; Nawarathna, U.; Fisher, K.; Shneerson, J.; Reddy, A.; Barker, R., 2015:
Sleep And Circadian Rhythm Regulation In Early Parkinson'S Disease

Masters, J.; Noyce, A.; Giovannoni, G.; Warner, T.; Proctor, G., 2015:
Elevated Salivary Dj-1 In Parkinson'S Disease Is Associated With Altered Salivary Secretion

Weston, P.; Paterson, R.; Lehmann, M.; M., M.; B., J.; Kayani, I.; D., J.; B., A.; C., D.; Ourselin, S.; Z., H.; T., J.; W., J.; Rossor, M.; Fox, N., 2015:
Using Florbetapir Pet To Increase Diagnostic Certainty In Atypical Dementias

Malik, G.A.; Joshi, Y., 2015:
First Case Series Of Venous Sinus Stenting In Iih Patients In Wales

Gorgoraptis, N.; Zaw-Linn, J.; Feeney, C.; Jimenez, C.T.; Niemi, M.; Malik, A.; Ham, T.; Baxter, D.; Goldstone, A.; Sharp, D., 2015:
The Impact Of Traumatic Brain Injury On Patient-Reported Physical And Mental Health

Adams, D.; Suhr, O.; Conceicao, I.; Waddington-Cruz, M.; Schmidt, H.; Buades, J.; Campistol, J.; Pouget, J.; Berk, J.; Coelho, T., 2015:
Phase 2 Open-Label Extension Study Of Patisiran, An Investigational Rnai Therapeutic For The Treatment Of Familial Amyloid Polyneuropathy

Kelsey, P.; B., S.; Jessop, H.; S., J.; Sharrack, B., 2015:
Autologous Haemopoietic Stem Cell Transplant In Ms: Sheffield Cohort

Thomson, A.; Davis, A.; Paterson, A.; Giovannoni, G.; Schmierer, K., 2015:
Designing An Information Resource To Explain Diagnostic Lumbar Puncture And Promote Best Practice

Miller, S.; Zrinzo, L.; Matharu, M., 2015:
Deep Brain Stimulation In Intractable Short-Lasting Unilateral Neuralgiform Headache Attacks: A Multicase Series

Ahmad, H.; Arshad, Q.; Patel, M.; Roberts, R.; Bronstein, A., 2015:
Acquired Pendular Nystagmus In Stargardt'S Syndrome Suppressed By Alcohol

Bashford, J.; Leschziner, G., 2015:
Bed Partner Gas-Lighting As A Cause Of Fictitious Sleep-Talking

Massey, T.; Pearson, O., 2015:
Severe (But Reversible) Cervical Cord And Brain Iris Reaction After Discontinuation Of Natalizumab In Pregnancy Of Patient With Multiple Sclerosis

Osman, C.; Clark, T.; Ghosh, B.; Halfpenny, C., 2015:
Tabes Dorsalis In The Post Antibiotic Era: Never Say Never

Rossor, A.; Josifova, D.; Howard, R.; IsaacsItua, A., 2015:
Motor Neuron Disease: A Case Of Misguided Therapeutic Nihilism

Vinjam, M.R.; Shanmugarajan, P.; Ford, H., 2015:
Stiff Person Syndrome Presenting As Stiff Eyes

Ashton, E.; Smeeton, B.; Weatherby, S., 2015:
One Year Retrospective Audit Of Cns Malignancy 2 Ww Referrals

Bose, P.; Palethorpe, D.; Marin, J.; N., A.; L., J.; G., P., 2015:
Indomethacin Test Usage At United Kingdom Tertiary Centres Over 20 Years-An Audit

Lynch, E., 2015:
Are Female Academic Neurologists Getting Their Voices Heard?

Edwards, A.; Percival, K.; Zouita, L.; Arevalo, J.; O'Dwyer, J.P., 2015:
Analysis Of Convulsive Seizures At A Dgh Emergency Department

Ng, M.J.; Anderson, J.M.; Joannides, A.J., 2015:
A Framework For Managing And Monitoring Neurology Referrals

Axinte, L.; Sawcer, S.; Stacpoole, S., 2015:
The Changing Face Of Acute Neurology: Experience From Two Decades Of The Cambridge Neurology Emergency Clinic

Thomas, R.; Devine, H.; Donnelly, A.; Foulkes, A.; Galtrey, C.; Khaleeli, Z.; Lawrence, J.; Novak, M.; Redgrave, J.; Tallantyre, E., 2015:
Why Neurology? The Career Choices Of Current Uk Neurology Trainees

Weerasinghe, K.C.; Sharma, A.; Weerasinghe, A.; Tung, P., 2015:
Ultrasound Assisted Lumbar Puncture; The Not-So-Steep Learning Curve

Jammeh, E.; Carroll, C.; Pearson, S.; Escudero, J.; Anastasiou, A.; Zajicek, J.; Ifeachor, E., 2015:
Using Nhs Primary Care Data To Identify Undiagnosed Dementia

Randall, A.; Ellis, R.J.B.; Hywel, B.; McCoy, C.A.; Davies, R.; Eldridge, P.R.; Putharan, M.; Radon, M.; Alusi, S., 2015:
Dural Avf Causing A Treatable Cjd Like Cognitive Dysfunction

Fletcher, P.; Schott, J.; Rossor, M.; Warren, J., 2015:
Abnormal Sound And Music Reward Processing In Dementia: A Behavioural And Neuroanatomical Analysis

Hobart, J.; Cleanthous, S.; Zajieck, J.; Cano, S., 2015:
Confusion In Clinical Trials Of Alzheimer'S Disease

Kamourieh, S.; Wise, R., 2015:
Dementia And The Cocktail Party Problem

Larner, A., 2015:
Mini-Addenbrooke'S Cognitive Examination (M-Ace): Pragmatic Study

Charalambous, N.; Goh, A.; Los, F.; Sharma, K., 2015:
Does Understanding Basic Neuroscience Cure Neurophobia?

O'Dowd, S.; Munteanu, T.; Hardiman, D.; Sheehy, N.; Redmond, J., 2015:
The Man Who Mistook The Fridge For A Door: An Atypical Presentation Of Dementia With Lewy Bodies

Yeo, J.M.; Waddell, B.; Khan, Z.; Pal, S., 2015:
A Systematic Review & Meta-Analysis Of F-18-Labelled Amyloid Imaging In Alzheimer'S Disease

Costa, R.; L., N.; G., H.; S., R.; N., T.; S.-Silva, P., 2015:
Safety And Efficacy Of Eslicarbazepine Acetate In Elderly Patients

Keddie, S.; Angus-Leppan, H.; Parker, T.; Toescu, S.; Nash, A.; Adewunmi, L.; Liu, R., 2015:
Discussing Sudden Unexpected Death In Epilepsy: Are We Empowering Our Patients?

French, J.; Krauss, G.; Wechsler, R.; Wang, X.; DiVentura, B.; Brandt, C.; Trinka, E.; O'Brien, T.; Laurenza, A.; Patten, A.; Bibbiani, F., 2015:
Adjunctive Perampanel Rct For Pgtc Seizures

Villanueva, V.; G., M.; G., F.L.; Rodriguez-Osorio, X.; U., J.R.; López-Gomáriz, E.; M., J.; A., J.P.; Molins, A.; S.-Diaz, R.; A., J.G.dela; Mauri, J.A.; Castillo, A.; P., F.L.-T.; Toledo, M., 2015:
Fydata Study: Perampanel Study In A Real-Life Setting

Elkommos, S.; Weber, B.; Niehusmann, P.; Volmering, E.; Richardson, M.; Marson, A.; Elger, C.; Keller, S., 2015:
Hippocampal Internal Architecture And Postoperative Outcome In Temporal Lobe Epilepsy

Fuller, S.; H., K.; J., D.K.; Gray, W.P., 2015:
Predicting Visual Field Defects Following Selective Transsylvian Amygdalohippocampectomy

Georgieva, Z.; Altemimi, H., 2015:
Impact Of A Clinical Pathway On The Management Of First Seizures At A District General Hospital

Jones, L.; Johnston, A., 2015:
Epilepsy In The Elderly: Getting To The Heart Of The Matter, A Case Report

Tudor, K.I.; Eames, S.; Haslam, C.; Panicker, J., 2015:
Barriers In Clinic To Discussing Sexual Dysfunction Due To Multiple Sclerosis

Aji, B.; Larner, A., 2015:
Screening For Dementia: Is 1 Simple Question The Answer?

Mahmood, F.; Zdebik, A.; Au, A.; Cooke, J.; Russell, C., 2015:
Valproic Acid Extends Lifespan Of The Zebrafish Model Of Cln2 Disease (Late Infantile Neuronal Ceroid Lipofuscinosis)

Pickrell, W.; Hope, C.; Higgins, A.; Mullins, J.; Smith, P.; Rees, M.; Chung, S., 2015:
A Novel Lgi1 Variant In Lateral Temporal Lobe Epilepsy

Wynford-Thomas, R.; Powell, R., 2015:
The Insula: Island Of Reil

Binks, S.; Green, L., 2015:
Front Door Neurology: The Gp Experience

Datta, S.; McIntosh, C.; Craven, I.; Macmullen-Price, J.; Jung, A.; Lily, O., 2015:
Cerebral Fat Embolism: Susceptibility-Weighted Imaging Is Useful And Prognosis Can Be Good

Morgan, C.; Wakerley, B.; Fuller, G., 2015:
Serial Nerve Conduction Studies In A Guillain-Barr Syndrome Variant: The Evolution Of Demyelinating Changes

Morrish, P., 2015:
What Is The Nin, And What Can It Do For You?

Morrish, P., 2015:
What Is The Nin Telling Us?

Shaw, S.; Ng, Y.S.; Whittaker, R.; McFarland, R.; Turnbull, D.; Gorman, G.; Schaefer, A., 2015:
A Clinical Audit Of Acute Management Of Stroke-Like Episodes From A National Mitochondrial Disease Centre

Tan, R.; Markus, H., 2015:
The Spectrum Of Migraine In 306 Patients With Cadasil

Reuber, M.; Toerien, M.; Wiseman, H.; Shaw, R.; Duncan, R., 2015:
Patient Satisfaction With Medical Encounters In Neurology Outpatient Clinics

Fox, R.; Gosal, D.; Ealing, J.; Murphy, H., 2015:
Clinical Manifestations Of Dnmt1 Mutations

Massey, T.; Hill, M.; Sadiq, S.; Smith, R., 2015:
Fever, Acute Hemiparesis, Aphasia, Status Epilepticus, Psychosis Migraine?

Pegg, E.; Dodd, K.; Shaunak, S., 2015:
Mitochondrial Cytopathy Presenting With Cerebellar Ataxia

Lad, M.; Parkinson, M.; Rai, M.; Pandolfo, M.; Murphy, S.; Emmanuel, A.; Panicker, J.; Giunti, P., 2015:
Urinary, Bowel And Sexual Function In Patients With Friedreich'S Ataxia

Abdel-Aziz, K.; Mirza, N.; Mbizvo, G.; Putharan, M.; Krishnan, A., 2015:
Dural Avm As A Cause Of Raised Pressure Symptoms In Treated Cvst

Al-Ansari, A.; Walters, R.J.L., 2015:
Case Report: Pourfour Du Petit Syndrome In A Patient With Migraine

Amin, R.; Hughes, T., 2015:
Headache In Miller-Fisher Syndrome

Angus-Leppan, H.; Guiloff, R.J., 2015:
Familial Migraine Limb Pain Syndrome (Mlps): Three Generations And Seven Year Follow-Up

Matar, M.; Sivagnanasundarum, J.; Harikrishnan, S., 2015:
Delayed Diagnosis Of Cadasil In A Patient With Hemiplegic Migraine

Gargalas, S.; David, A.; Khan-Bourne, N.; Shotbolt, P.; Weeks, R., 2015:
Characteristics Of Functional And Organic Stroke Mimics

Karsan, N.; Palethorpe, D.; Bhola, R.; Goadsby, J.M.,P., 2015:
Flunarizine In Primary Headache Disorders

Miller, S.; Fox, Z.; Watkins, L.; Matharu, M., 2015:
Occipital Nerve Stimulation In Highly Refractory Chronic Headaches: Identification Of Possible Predictors Of Success

Ralston, K., 2015:
The Management Of Migraine In Primary Care

Vanderpol, J.; Bishop, B.; Matharu, M.; Glencorse, M., 2015:
Therapeutic Effect Of Intranasal Evaporative Cooling In Patients With Migraine. A Report Of The Results Of The Cool Head I, Pilot Study

Dodd, K.; Pegg, E.; Brown, R.; Shaunak, S., 2015:
Treatment Of Neurological Manifestations Of Sjogren'S Syndrome

Sturrock, A.; Karim, A.; Denniston, A.; Jacob, S., 2015:
Autoimmune Retinopathy Importance Of Recoverin B Antibodies

Kemp, M.; Kimber, J.; Zhang, L., 2015:
Anti-Voltage Gated Potassium Channel (Vgkc) Antibody Positive Encephalopathy

Binks, S.; Cooper, R.; Wood, R.; Martin, L., 2015:
Management Of Suspected Encephalitis In A Uk Teaching Hospital

Llewelyn, D.; Fish, M., 2015:
The Management Of Suspected Encephalitis At A Regional District General Hospital

Westwood, K.; Ealing, J.; Taylor, M.; Worth, P.; Nemeth, A., 2015:
The Known Uk Cases Of Ataxia Telangiectasia-Like Disorder (Atld)

Maxwell, A.; Archer, H.; Cohen, N.; Love, S.; Cottrell, D., 2015:
Progressive Multifocal Leucoencephalopathy: An Atypical Case

Vinjam, M.R.; Butterworth, S.; Davey, R., 2015:
Sporadic Creutzfeldt-Jakob Disease Presenting With A Jerky Alien Limb

Witherick, J.; Bovill, B.; Dong, A.; Albur, M.; Bosnell, R., 2015:
Digging Deeper

Koopman, H.; Jackson, S.; Anichtchik, O.; Carroll, C., 2015:
Lps Induces Aggregation Of -Synuclein In Monocytes

Noad, R.; Newman, C.; Carroll, C.; Zajicek, J., 2015:
IPad-Based Assessment In Parkinson'S Disease

Coles, A.; Redfern, C., 2015:
Parkinson'S Disease And Spirituality

Jaffer, F.; Avbersek, A.; Iahrc, ; Enrah, ; Hanna, M.G.; Houlden, H.; Kaski, J.P.; Cross, H.; Sisodiya, S.M., 2015:
Ecg Abnormalities In Alternating Hemiplegia: A Broadened Phenotype

Bonello, M.; Larner, A., 2015:
Is The Applause Sign Useful For Diagnosis Of Dementia And Mci?

Adams-Carr, K.; Schrag, A.; Shribman, S.; Bestwick, J.; Lees, A.; Noyce, A., 2015:
Constipation Preceding Parkinson'S DiseaseMeta-Analysis

Sadnicka, A.; Daum, C.; Manohar, S.; Rothwell, J.; Edwards, M., 2015:
Discrimination In Dystonia: Time For A Rethink?

Kimura, A.; Takemura, M.; Saito, K.; Yoshikura, N.; Hayashi, Y.; Inuzuka, T., 2017:
Association between naturally occurring anti-amyloid autoantibodies and medial temporal lobe atrophy in Alzheimer's disease

Bañez-Coronel, M.; Ayhan, F.; Tarabochia, A.D.; Zu, T.; Perez, B.A.; Tusi, S.K.; Pletnikova, O.; Borchelt, D.R.; Ross, C.A.; Margolis, R.L.; T Yachnis, A.; Troncoso, J.C.; PWRanum, L., 2016:
A1New starts and directions: understanding the role of hidden expansion proteins in Hd

Reilmann, R., 2016:
A10Hd minipigs behavioural and imaging protocols transitioning into preclinical trials

Wild, E.J., 2016:
D1Hdclarity: a multi-site cerebrospinal fluid collection initiative to facilitate therapeutic development for huntingtons disease

Niemelä, V.; Blennow, K.; Landtblom, A.-M.; Sundblom, J., 2016:
D2Cerebrospinal fluid biomarkers in huntingtons disease

López-Sendón Moreno, J.L.; García-Caldentey, J.; Barral, V.M.; Fraga, C.E.; Perdices, N.J.; de Yébenes, J.G., 2016:
D3Csf proteins, monoamines, endocannabinoids and Bdnf levels in a trial with sativex in huntingtons disease

Byrne, L.; Rodrigues, F.B.; Tabrizi, S.J.; Zetterberg, H.; Wild, E.J., 2016:
D4Prediction of huntingtons disease phenotype by cerebrospinal fluid biomarkers of inflammation and cell death

Unti, E.; Mazzucchi, S.; Palermo, G.; Palego, L.; Giannaccini, G.; Frosini, D.; Gamba, C.D.; Bonuccelli, U.; Ceravolo, R., 2016:
D5Oxytocin plasma levels as predictor of social cognition in huntingtons disease

Ferraldeschi, M.; Romano, S.; Delmondo, A.; M., A.; S., M.; Frontali, M.; Ristori, G.; P., A., 2016:
D6Dna damage in lymphocytes as a predictor of illness evolution in pre-manifest and overt huntingtons disease

Kersten, H.; Danesh-Meyer, H.; Kilfoyle, D.; Roxburgh, R., 2016:
D7Optical coherence tomography findings in huntingtons disease: a potential biomarker of disease progression

Orth, M.; Mayer, I.M.S.; Tabrizi, S.J.; Rothwell, J.C.; Casula, E., 2016:
D8Tms-eeg markers of inhibitory deficits in huntingtons disease

Johnson, E.B.; Dürr, A.; Leavitt, B.; Roos, R.A.C.; Langbehn, D.R.; Tabriz, S.J.; Scahill, R.I., 2016:
D9An evaluation of methods for the volumetric measurement of grey matter in huntingtons disease

Coppen, E.; Grond, J.vander; Hafkemeijer, A.; Rombouts, S.; Roos, R., 2016:
D10Early changes in structural covariance networks in huntingtons disease

WSChan, A., 2016:
A11Longitudinal assessment of a nonhuman primate model of huntingtons disease

Liu, W.; Chen, K.; Yang, J.; Burgunder, J.-M.; Cheng, B.; Shang, H., 2016:
D11Diffusion imaging studies of huntingtons disease: a meta-analysis

Georgiou-Karistianis, N.; Stout, J.C.; Churchyard, A.; Chua, P.; Egan, G.F.; Poudel, G., 2016:
D12Longitudinal change in structural connectome in huntingtons disease: the image-hd study

Dogan, I.; Werner, C.J.; Mirzazade, S.; Schiefer, J.; Schulz, J.B.; Reetz, K., 2016:
D14Resting-state connectivity changes in huntingtons disease: a follow-up study

Crawford, H.; Langbehn, D.R.; Scahill, R.I.; Rees, G.; Tabrizi, S.J.; Orth, M.; Gregory, S., 2016:
D16White matter microstructure and natural biological variation in huntingtons disease

McColgan, P.; Razi, A.; Seunarine, K.K.; Gregory, S.; Durr, A.; Roos, R.A.C.; Scahill, R.I.; Clark, C.A.; Rees, G.; Tabrizi, S.J., 2016:
D18Brain network breakdown and pathophysiological correlates in huntingtons disease

Gargouri, F.; Messé, A.; Perlbarg, V.; Valabregue, R.; McColgan, P.; Yahia-Cherif, L.; Fernandez-Vidal, S.; Hamida, A.B.; Benali, H.; Tabrizi, S.; Durr, A.; Lehéricy, S., 2016:
D19Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifest and premanifest huntingtons disease

Gregory, S.; Long, J.D.; Klöppel, S.; Razi, A.; Scheller, E.; Minkova, L.; Papoutsi, M.; Mills, J.A.; Stout, J.; Scahill, R.I.; Langbehn, D.R.; Tabrizi, S.J.; Rees, G., 2016:
D20Operationalising compensation over time in neurodegenerative disease

McLean, T.; Mestre, T.; Levey, J.; Handley, O.; Landwehrmeyer, B.; Sampaio, C., 2016:
A12How does Enroll-Hd expedite/facilitate the conduct of clinical trials?

Gregory, S.; Klöppel, S.; Long, J.D.; Razi, A.; Scheller, E.; Minkova, L.; Dürr, A.; Roos, R.A.C.; Leavitt, B.R.; Mills, J.A.; Stout, J.; Scahill, R.I.; Langbehn, D.R.; Rees, G.; Tabrizi, S.J., 2016:
D21Longitudinal compensation in the cognitive network in huntingtons disease

Gregory, S.; Klöppel, S.; Scheller, E.; Minkova, L.; Razi, A.; Durr, A.; Roos, R.A.C.; Leavitt, B.R.; Papoutsi, M.; Bernhard Landwehrmeyer, G.; R., R.; Borowsky, B.; Johnson, H.; Mills, J.A.; Owen, G., 2016:
D22Compensation in preclinical huntingtons disease: evidence from the track-on Hd study

Garcia-Gorro, C.; Garau-Rolandi, M.; Escrichs, A.; Rodriguez-Dechicha, N.; Martinez-Horta, S.; Vaquer, I.; Calopa, M.; Perez, J.; Muñoz, E.; Santacruz, P.; Ruiz, J.M.; Mareca, C.; Caballol, N.; Kulisevsky, J.; Subira, S., 2016:
D23The effect of cognitive reserve on age of onset and executive functions in huntingtons disease and its neurobiological bases

Marco-Garcia, S.; Garcia-Gorro, C.; Orpella-Garcia, J.; Rodriguez-Dechicha, N.; Martinez-Horta, S.; Vaquer, I.; Calopa, M.; Perez, J.; Muñoz, E.; Santacruz, P.; Ruiz, J.M.; Mareca, C.; Caballol, N.; Kulisevsky, J.; Subira, S., 2016 :
D24Intact emotional impulsivity in huntingtons disease despite altered structural connectivity in the uncinate fasciculus

Eddy, C.M.; Rickards, H.E.; Hansen, P.C., 2016:
D25Frontal and inferior-parietal cortex contributions to empathy in huntingtons disease

Reetz, K.; Giehl, K.; Dogan, I.; Werner, C.J.; Hammes, J.; Schulz, J.B.; Neumaier, B.; Drzezga, A.; Eimeren, T.van, 2016:
D26Pathological tau signal in huntingtons disease an in vivo [18F]-Av-1451 pet imaging report

Trender-Gerhard, I.; McDonald, K.; Talbot, P.; Craufurd, D.; Gerhard, A., 2016:
D27Neuroinflammation and changes in serotonin metabolism in presymptomatic Hd gene carriers: a dual tracer positron emission tomography (Pet) study

Ross, C.A.; Reilmann, R., 2016:
E1Diagnostic criteria for huntingtons disease based on natural history

Jacobs, M.; Hart, E.P.; van Zwet, E.W.; Bentivoglio, A.R.; Burgunder, J.-M.; Craufurd, D.; Reilmann, R.; Saft, C.; Roos, R.A.C., 2016:
E2Progression of motor subtypes in huntingtons disease: a six-year follow-up study

Yebenes, J.G.de; Mena, M.A.; Lopez Sendon, J.L.; Morales, B.; Fraga, M.; Pancorbo, J.; Marina, J.L., 2016:
E3Quantitative video analysis of cranial and facial movements in huntingtons disease and other movement disorders

Landwehrmeyer, B., 2016:
A13How does Enroll-Hd advance human research in Hd?

Lucia, N.D.; Peluso, S.; Maio, L.D.; Salvatore, E.; Michele, G.D., 2016:
E5Akinetic mutism in huntingtons disease: a case study

Ekwall, C.; Karlsson, M.; Sandell, M.; Hellström, K., 2016:
E6The correlation between eye movements and balance in a group of persons with huntingtons disease

Nanetti, L.; Nava, S.; Contarino, V.; Frittoli, S.; Ciammola, A.; Castaldo, A.; Bruzzone, M.G.; Gellera, C.; Grisoli, M.; Mariotti, C., 2016:
E7Posturography and mri study in premanifest huntingtons disease subjects to investigate stance abnormalities and early markers of neurodegeneration

Kegelmeyer, D.; Kloos, A.; Fritz, N.; Chaudhari, A.; Kostyk, S., 2016:
E8Trunk sway relates to gait and mobility measures and provides insight into increased fall risk in younger individuals with huntingtons disease

Rao, A.K.; Porciuncula, F.; Marder, K.S., 2016:
E9Impairment in gait speed modulation associated with functional mobility in huntingtons disease

Schubert, R.; Weber, N.; Reilmann, R., 2016:
F1Q-Cog a cognitive assessment battery for huntingtons disease

Baake, V.; HAMReijntjes, R.; Dumas, E.M.; Thompson, J.; ACRoos, R., 2016:
F2Longitudinal evaluation of the registry cognitive battery across the different stages of huntingtons disease

Muratori, L.M.; Evinger, L.; Reilmann, R., 2016:
F3Biological motion perception in huntingtons disease

Martinez-Horta, S.; Perez-Perez, J.; Horta-Barba, A.; Pagonabarraga, J.; Kulisevsky, J., 2016:
F4Neurophysiological and behavioural evidence of posterior-cortical alterations associated to specific deficits on face-pareidolia recognition in premanifest huntingtons disease

Unti, E.; Mazzucchi, S.; Palermo, G.; Kiferle, L.; Pagni, C.; Tognoni, G.; Bonuccelli, U.; Ceravolo, R., 2016:
F5Social cognition in huntingtons disease: evidence from a prospective study

Castaldo, A.; Nanetti, L.; Bachoud-Lévi, A.-C.; Giavazzi, M.; Contarino, V.; Nava, S.; Mongelli, A.; Gellera, C.; Grisoli, M.; Bruzzone, M.G.; Bella, D.D.; Ciammola, A.; Taroni, F.; Mariotti, C., 2016:
F6Does premanifest Hd perform worse in arithmetic? Symbol digit and calculation tests confirm early cognitive impairment in preHd and correlate with brain Mri abnormalities

Glikmann-Johnston, Y.; Fink, K.D.; Torrest, A.; Nolta, J.A.; Stout, J.C., 2016:
F7Spatial memory in huntingtons disease: a comparative review of human and animal data

Harris, K.; Mason, S.; Barker, R., 2016:
F8Hippocampal abnormalities in premanifest and early stage huntingtons disease

Júlio, F.; Malhão, A.; Pedrosa, F.; Gonçalves, H.; Simões, M.; Simões, M.R.; Asselen, M.van; Castelo-Branco, M.; Januário, C., 2016:
F9Everyday executive function in huntingtons disease: early deficits assessed by a virtual reality task

Ordóñez, K.L.; Cubo, E.; Polo, C.G.; Pérez, N.M.; Siscart, I.M.; Hernández, J.S.; Bartolomé, M.V.P.; Moja, L.C.G.ía, 2016:
F10Analysis of performance in two different versions of stroop test in manifest and pre-manifest patients with huntingtons disease of burgos (Spain)

Ho, A.K.; Barker, R.A.; Pritchard, H.J., 2016:
F11Verbal memory in huntingtons disease: a longitudinal study

Saft, C.; Grönheit, W.; Lukas, C.; Bellenberg, B.; Hein, S.von; Hoffmann, R.; Skodda, S., 2016:
F12Pa Pa Pa and Pati Pati Pati do Hd mutation carriers have an evolutionary advantage?

Hinzen, W.; Morey, C.; Rossello, J.; Salvador, R.; Garcia-Gorro, C.; Camara, E.; Diego-Balaguer, R.de, 2016:
F13Deviant language patterns in huntingtons spontaneous speech

Ordóñez, K.L.; Cubo, E.; Polo, C.G.; Pérez, N.M.; Siscart, I.M.; Hernández, J.S.; Bartolomé, M.V.P.; Moja, L.C.G.ía, 2016:
F14The F.A.S. versus P.M.R phonological verbal fluency in manifest and pre-manifest patients with huntingtons disease of burgos (Spain)

Quinn, L., 2016:
A15Can exercise and physical therapy alter disease progression in huntingtons disease?

Ruiz-Idiago, J.; Tovar, A.; Hinzen, W.; Rosselló, J.; Pomarol-Clotet, E.; Roy-Millán, P., 2016:
F15Asymptomatic carriers and early stages huntingtons disease patients show an impaired linguistic profile

Manor, Y.; Shpunt, D.; Naor, S.; Sendler, N.; Frydman, L.; Gad, A.; Ezra, A.; Migirov, A.; Knaani, J.; Socher, A.; Gurevich, T., 2016:
F16Communication and language skills in huntingtons disease

Andrews, S.C.; Craufurd, D.; Tabrizi, S.; Stout, J.C., 2016:
G1Executive task performance and anxiety are associated with self-awareness of neuropsychiatric symptoms in huntingtons disease

McLauchlan, D.; Craufurd, D.; Linden, D.; Rosser, A., 2016:
G2Huntingtons disease patients are stuck in a rut: objective testing of apathy in huntingtons disease

Marxreiter, F.; Mrochen, A.; Kozay, C.; Regensburger, M.; Klucken, J.; Winkler, J.; Kohl, Z., 2016:
G3Hedonic olfaction in huntingtons disease

McLauchlan, D.; Craufurd, D.; Linden, D.; Rosser, A., 2016:
G4Limited insight? Objective testing of irritability in huntingtons disease

Hoffmann, R.; Brüne, M.; Hein, S.von; Klotz, P.; Saft, C., 2016:
G5Are Ocd-symptoms overdiagnosed in huntingtons disease?

Yixuan, Z.; Tengteng, W.; Xunhua, L.; Xiuling, L.; Zhong, P., 2016:
G6Behaviour problem of chinese huntington disease patients

Higgins, A.; Hoblyn, J., 2016:
G7A review of neuropsychological and neuropsychiatric symptom emergence in a long-term setting; what can we learn about symptom management?

Heemskerk, A.-W., 2016:
H1Dysphagia in huntingtons disease: symptoms and a patient perspective

Fisher, B., 2016:
A16Exercise-induced brain repair in neurodegeneration: what can we learn from parkinsons disease?

Schradt, F.; Geitner, C.; Lindner-Pfleghar, B.; Rea, D.; Hamilton, A.; Lang, C.; Süssmuth, S.D.; Weydt, P.; Schumann, B.; Werner, C., 2016:
H2Dysphagia in huntingtons disease (Hd): a longitudinal, observational study

Manor, Y.; Shpunt, D.; Avniel, M.; Assa, D.; Torner, Y.; Gad, A.; Ezra, A.; Knaani, J.; Socher, A.; Oestriecher-Kedem, Y.; Gurevich, T., 2016:
H3Swallowing disorders characteristics and the relation to cognitive level, disease duration and disease severity in patients with huntingtons disease

Vreede, P.de; Veldkamp, F.; Achterberg, W., 2016:
H4Measuring body composition in huntingtons disease

Rivadeneyra, J.; Cubo, E.; Calvo, S.; Mariscal, N.; Acera, M.; Gómez, J.; Berganzo, K., 2016:
H5Calf circumference and body composition in huntingtons disease

Heemskerk, A.-W., 2016:
H6Oral feeding in huntingtons disease: a dutch guideline for speech and language therapists

Sandler, S.S., 2016:
H7The history of huntingtons nutrition

Baig, S.; Strong, M.; Quarrell, O., 2016 :
I1The prevalence of huntingtons disease (Hd): a systematic review of reports published since 1993

Kay, C.; Collins, J.; Miedzybrodzka, Z.; Wright, G.; Madore, S.; Gordon, E.; Gerry, N.; Fisher, E.; Davidson, M.; Slama, R.; Hayden, M., 2016:
I2Huntingtons disease reduced penetrance alleles occur at high frequency and affect age-related increases in prevalence

Stumpo, M.; Guttmann, S.; Volpini, M.; Monaldini, C.; Manzaroli, D.; Maffi, S.; Consoli, F.; Squitieri, F., 2016:
I3High prevalence of huntingtons disease in San Marino Republic: an epidemiological survey

Demetriou, C.A.; Salafori, C.; Christou, Y.; Heraclides, A.; Zamba-Papanicolaou, E., 2016:
I4Epidemiology of huntingtons disease in cyprus: in search of a founder effect

Papoutsi, M.; Weiskopf, N.; Langbehn, D.; Reilmann, R.; Rees, G.; Tabrizi, S.J., 2016:
A17Hd brain-train: neuroplasticity as a target to improve function in huntingtons disease

Alencar, M.A.; Figueiredo, E.; Porciúncula, C.; Monlleó, I., 2016:
I5Huntingtons disease and prevalence in Brazil

Moily, N.S.; Kota, L.N.; Anjanappa, R.M.; Venugopal, S.; Vaidyanathan, R.; Pal, P.; Purushottam, M.; Jain, S.; Kandasamy, M., 2016:
I6Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European Haplogroup A

Saifulliina, E.; Magzhanov, R., 2016:
I7Reproductive behaviour of patients with huntingtons disease

Gardiner, S.L.; van Belzen, M.J.; Boogaard, M.W.; MCvan Roon-Mom, W.; Rozing, M.P.; van Hemert, A.M.; Smit, J.H.; TFBeekman, A.; Grootheest, G.van; Schoevers, R.A.; Comijs, H.C.; WJHPenninx, B.; van der Mast, R.C.; ACRoos, R.; Ahmad Aziz, N., 2016:
I8Huntingtin gene repeat polymorphisms affect risk of lifetime depression in the general population

Seliverstov, Y.; investigators, E.H.D.; Illarioshkin, S.; Landwehrmeyer, B.; Belyaev, M., 2016:
I9The size of the Cag-expansion mutation can be predicted in hd based on phenotypic data using a machine learning approach

Marano, M.; Migliore, S.; Maffi, S.; Consoli, F.; Squitieri, F., 2016:
I10Cross-sectional and longitudinal analysis in juvenile huntington disease in italy

Nopoulos, P.; Moser, A.; Slevinski, S., 2016:
I11Common but unrecognised symptoms in juvenile huntingtons disease (Jhd)

Nopoulos, P.; Lee, J.; Epping, E.; Martin, E.; Mathews, K.; Espe-Pfeiffer, P.; Magnotta, V., 2016:
I12The role of the cerebellum in juvenile huntingtons disease (Jhd)

Solberg, O.; Feragen, K.B., 2016:
I13Can I be old with huntingtons disease (Hd)?

Hywood, J.; Teixeira-Pinto, A.; Nasserinejad, K.; McCusker, E.; Loy, C., 2016:
I14Predicting individual disease progression in huntingtons disease using mixed models and transition models

Rosser, A., 2016:
A18Is cell replacement a feasible option for huntingtons disease

Mariotti, C.; Nanetti, L.; Castaldo, A.; Mongelli, A.; Rizzo, E.; Grisoli, M.; Taroni, F.; Gellera, C., 2016:
I16Very slow disease progression in two hd patients carrying 40 and 45 cag repeats: a 10-year follow-up observational report

Ho, A.K.; Smith, P., 2016:
I17Predicting generic quality of life scores using the HdqoL

Ho, A.K.; Hocaoglu, M.; Gaffan, E., 2016 :
I18The HdqoL depicts disease stages more comprehensively relative to generic quality of life measures: initial pilot data

Ho, A.K.; Horton, M.C.; Tennant, A., 2016:
I19Further work on validating the huntingtons disease quality of life questionnaire (HdqoL)

Szejko, N.; Milanowski, L.; Jamrozik, Z.; Janik, P., 2016:
I20The assessment of quality of life in patients with moderately advanced huntingtons disease

Fossmo, H.L.; Walsem, M.V.; Frich, J., 2016:
I21Self-reported physical activity, health-related quality of life and life satisfaction in huntingtons disease

Afridi, F.K.; Malik, J.A.; Khan, M.S., 2016:
I22Explaining quality of life of students at risk of huntingtons disease: a moderated-mediated model of risk and protective factors

Afridi, F.K.; Malik, J.A.; Khan, M.S., 2016:
I23Relationship between stress and quality of life in students at risk of huntingtons disease: changing patterns of social support across age

Signer, E., 2016:
A19Conjecture; Hd research outside the box

Baake, V.; Hart, E.; Bos, R.; Roos, R., 2016:
I27Participants at the leiden site of the registry study: a demographic approach

Orth, M.; Bronzova, J.; Tritsch, C.; Dorsey, R.; Ferreira, J.J.; Gemperli, A., 2016:
I29Comparison of huntingtons disease in europe and North America

Handley, O.; Mestre, T.; Levey, J.; McLean, T.; Landwehrmeyer, B.; Sampaio, C., 2016:
I30Enroll-Hd: a global clinical research platform for huntingtons disease

Handley, O.; Mestre, T.; Levey, J.; McLean, T.; Landwehrmeyer, B.; Sampaio, C., 2016:
I31Enroll-Hd: current status

Corey-Bloom, J.; Long, J.D.; Fitzer-Attas, C.J.; Landwehrmeyer, B.; Sampaio, C., 2016:
I32Using the global clinical research platform of enroll-hd to facilitate the enrollment of premanifest huntington disease (Hd) participants in clinical trials

Iseni, J.; Jacob, O., 2016:
I33Data quality indicators for huntingtons disease observational studies; data quality indicators framework an explorative study

Monckton, D.; Ciosi, M.; Mubarak, A.; Cumming, S.; Hamilton, G.; Maxwell, A., 2016:
A2Cryptic polyglutamine repeat sequence variation and somatic instability in huntingtons disease: drivers of pathology?

Forman, H.J., 2016:
A20An introduction to Nrf2, the master rheostat for antioxidant-inflammatory homeostasis

Schultz, J.; Nopoulos, P.; Moser, D.; Paulsen, J.; Kamholz, J., 2016:
I35Substance abuse leads to earlier age of onset of huntingtons disease: an epidemiological study of the Enroll-Hd database

Turner, R.; Chu, E., 2016:
I36Forensic risk in huntingtons disease

Yohrling, G.; Vetter, L., 2016:
I37Hd trialfinder: a clinical trial matching resource for the Hd community

Cichecki, F.; Witkowski, G.; Zielonka, D.; Sienkiewicz-Jarosz, H.; Stepniak, I.; Ziora-Jakutowicz, K., 2016:
I39Treatment of chorea and its efficacy in huntingtons disease (Hd) patients

Claassen, D.O.; Boer, L.D.; Iyer, R.; Ayyagari, R.; Mu, F.; Gandhi, S.; Carroll, B.; Stamler, D., 2016:
I40Number needed to harm (Nnh) analysis of deutetrabenazine (Dtb) and tetrabenazine (Tbz) from two pivotal trials: First-Hd and Tetra-Hd

Claassen, D.O.; Iyer, R.; Dimbil, M.; Giron, A.; DeBoer, L.; Gandhi, S.; Hoffman, K.B., 2016:
I41Post-marketing adverse events (Aes) associated with tetrabenazine (Tbz): findings using Fdas adverse event reporting system (Faers)

Elaswed, A., 2016:
I42Treatment of rigidity in huntingtons disease (a literature review)

Inbar, N.; Quinn, L.; Hamana, K.; Busse, M., 2016:
I43Functional screening for huntingtons disease: a phased approach

Klooster, J.; Kremer, B.; Huitema, R., 2016:
I44Fitness-to-drive in huntingtons disease

Bresciani, A.; Cerretani, M.; D’Amico, M.; Fezzardi, P.; Gallo, M.; Missineo, A.; Moretti, D.; Santoprete, A.; Tambone, S.; Tomei, L.; Dominguez, C.; Sanjuan, I.M.; Sherman, L.T.; Park, L., 2016:
A21Development of an Nrf2-Keap1 protein-protein disruptor for proof of concept

Zielonka, D.; Puch, E.A., 2016:
I45Alternative medicine methods utilisation in huntingtons disease

Slobbe, A.; Slats, D.; Ja, S.; Bogaard, vanden; Roos, R.A.C.; Spierenburg, A.; Achterberg, W.P., 2016:
I46Polypharmacy in patients with advanced huntingtons disease residing in a nursing home

Clenaghan, C.; C., R.; H., J.; K., S.; H., J.; K., S.; M.Lauchlan, D.; R., A., 2016:
I47Recognising serious comorbidities in huntingtons disease

Quarrell, O.; Baig, S.; Strong, M.; Rosser, E.; Taverner, N.; Glew, R.; Miedzybrodzka, Z.; Clarke, A.; Craufurd, D., 2016 :
J1Predictive testing for huntingtons disease (Hd) in the Uk 1994 2014: changes in age distribution and outcome of results

Bonnard, A.; Herson, A.; Staraci, S.; Gargiulo, M.; Durr, A., 2016:
J5Outcome in 25% at-risk individuals after presymptomatic testing for huntingtons disease

Gibbons, C.A.; Medved, W.; Meschino, W.S.; Lefebvre, A.; Alan Fung, W.L.; Semotok, J., 2016:
J6Parents perspective on the challenges of disclosing huntingtons disease information to their at risk children

Heller, H.; Blancato, J.; Cummings, T.; Amjad, F.; Shoulson, I.; Pagan, F.; Anderson, K., 2016:
J7Intermediate allele expansion leads to huntingtons disease expression in large kindred

Johnson, J.; Johnson, D.; Brautigam, H., 2016:
A22Genetic tools to validate and measure Nrf2 in Hd

Bailey, J.; Lahiri, N.; McEntagart, M.; Eddy, C.; Crosby, C.; Perez-Caballero, A.; Gibbons, C.; Meschino, W., 2016:
J8Two case studies demonstrating transmission of unstable huntingtons disease intermediate alleles and the implications for genetic counselling practice

Koriath, C.; Adamson, G.; Druyeh, R.; Kenny, J.; Collinge, J.; Wild, E.; Houlden, H.; Gaskin, M.; Mead, S.; Tabrizi, S., 2016:
J9Probing huntingtons disease phenocopy syndromes with next-generation sequencing

Paucar, M.; Pajak, A.; Freyer, C.; Stranneheim, H.; Wedell, A.; Wredenberg, A.; Svenningsson, P., 2016:
J10Chorea, psychotic symptoms and long survival in a subject with Elac2 mutations

Baine, F.K.; Krause, A., 2016:
J11Investigating phenocopies in a cohort of south african patients with a huntingtons disease-like phenotype

Walsem, M.R.van; Howe, E.I.; Frich, J.; Andelic, N., 2016:
K1Gaps between needs and provision of services in huntingtons disease: a cross-sectional population study

Rae, D.; Ross, A.; Miedzybrodzka, Z., 2016:
K2International guidelines project: an update of non-pharmacological recommendations for huntingtons disease care

Rae, D.; McDermott, A.; Miedzybrodzka, Z.; Campbell, M.; Gillies, K., 2016:
K3Towards improvement in care delivery in huntingtons disease: improve Hd

Rodrigues, F.B.; Tabrizi, S.J.; Taylor, R.; Wild, E.J., 2016:
K4The cost and value of a huntingtons disease multidisciplinary team meeting

Minster, S.; Williams, S., 2016:
K6Understanding the Hd care pathway from an operations management perspective

Wipke, B., 2016:
A23What can Hd learn from the development of dimethyl fumarate (Tecfidera ) for multiple sclerosis?

Demeulenaere, S.; Dachelet, J., 2016:
K7A method for advance care planning with Hd-patients

Engelhard, D.; Achterberg, W., 2016:
K8Patient perspectives on research themes in advanced huntingtons diseases

Cann, R.; Quarrell, O.; Curtis, P., 2016:
K9Families perspectives on the potential of a virtual Mdt for patients with Jhd

Man, J.de; Jager, L.de; Kleiterp, J.; Engelhard, D.; Achterberg, W., 2016:
K10E-health support for community residing Hd patients: report of a pilot-project

Kavanaugh, M.; Swope, C.; Ellison, M., 2016:
K12Supporting youth affected by Hd: results from the north american youth summer camp evaluation

Hermant, E.; Pihet, V.; Jeandel, J.; Solhdju, K., 2016:
K13Composing with huntingtons

Simpson, J.; Theed, R.; Eccles, F., 2016:
K14Understandings of psychological difficulties in people with huntingtons disease and their expectations of psychological therapy

Veenhuizen, R.; Buul, L.van; Messchaert, E.; Hertogh, C., 2016:
K16Patient and informal caregiver outreaching care for huntingtons (Picoh): a pilot study on crisis occurrence and prevention

Meer, L.vander, 2016:
A24Huntingtons disease: the importance of personal relationships in early life and adulthood

Venkatesh, S.D.; Sharma, K.; Purushottam, M.; Pal, P.K.; Jain, S., 2016:
K18Assesment of functional and behavioural aspects in huntingtons disease patients

Higgins, A.; Hoblyn, J., 2016:
K19Enabling staff to manage challenging behaviour using a positive behaviour support approach; a study of the impact of a six week on-ward program

Veenhuizen, R.; Jager, L.de; Lammertsen, K.; Nijsten, H.; Doelen, R.vander; Heffels, J.; Wagenaar, J., 2016:
K21Consensus on the functional diagnosis and treatment of ambulatory huntingtons disease patients. a problem oriented goal directed approach

Kerkdijk, E.; Nieuwkamp, M.; Verschuur, E., 2016:
K22Eline speaks; a communication application on iPads supporting communication of patients with huntingtons disease

Page, K.; Oakley, L.; Hill, P.; Fisher, A.; Carter, Z.; Kerrell-Vaughan, S., 2016:
K23Huntingtons disease clinical tips for occupational therapists

Heffels, J.; Kampen, M.van; Maanen, M.van; Clemens, M.; Vink, W.; Houkes, M.; Thijssen, A.; Egmond, K.van; Zwart, M., 2016:
K24Collaboration of occupational therapists in The Netherlands

Higgins, A.; Hoblyn, J., 2016:
K25A review of a 16-week intensive assessment and intervention program for community-dwelling patients with huntingtons disease

Brabcová, L.; Roth, J.; Ulmanová, O.; Horáček, O.; Kolářová, M.; Božková, H.; Rusz, J.; Košková, P.; Lísalová, K.; Jančok, F.; Klempíř, J.; Růžička, E.; Brožová, H., 2016:
K26Specific in-patient rehabilitation improves postural and gait instability in huntingtons disease

Duijn, E.van, 2016:
A25When life becomes too burdensome: suicidal ideation and suicidal behaviour

Veldkamp, F.; Vreede, P.de; Achterberg, W., 2016:
K27What do dutch dietitians know about huntingtons disease?

Maffi, S.; Migliore, S.; Marano, M.; Stumpo, M.; D’Alessio, B.; Squitieri, F., 2016:
K31Lega Italiana Ricerca Huntington (Lirh-rome) foundation as a network facilitator for assisting patients of italian origin: insight from Enroll-Hd

Caletti, E., 2016:
K32The italian way: to meet Hd families needs through design

Monteys, A.M.; Ebanks, S.A.; Keiser, M.S.; Davidson, B.L., 2016:
L1Crispr/Cas9 specific editing of the mutant huntingtin allele

González-Barriga, A.; Kourkouta, E.; Kontkanen, O.; Heikkinen, T.; Lehtimäki, K.; Deutekom, J.C.T.; Datson, N.A., 2016:
L2The expanded cag repeat in the huntingtin gene as target for therapeutic Rna modulation throughout the R6/2 and Q175 Hd mouse brain

Farshim, P.P.; Deverman, B.E.; Bates, G.P., 2016:
L3Systemic administration of a novel Aav variant results in widespread and efficient gene transfer in R6/2 mice

Evers, M.; Miniarikova, J.; Blits, B.; Spronck, L.; Brouwers, C.; Déglon, N.; Motlik, J.; Bankiewicz, K.; Southwell, A.; Haan, M.de; Richard, C.; Petry, H.; Konstantinova, P., 2016:
L4Sustained and strong Htt silencing by Aav5-miHtt as therapy for huntingtons disease

Paulsen, J.S., 2016:
A26Cognitive and behavioural changes in prodromal and diagnosed hd

Miniarikova, J.; Zanella, I.; Blits, B.; Evers, M.; Zimmer, V.; Spoerl, A.; Southwell, A.; Hayden, M.; Deventer, S.van; Deglon, N.; Petry, H.; Konstantinova, P., 2016:
L5Pre-clinical evaluation of aav5-mihtt gene therapy of huntingtons disease in rodents

Miralles, M.G.; Tan, L.J.; Lim, M.; Geva, M.; Hayden, M.R.; Pouladi, M.A., 2016:
L6Evaluation of pridopidine in the transgenic yac128 mouse model of huntingtons disease

Ellrichmann, G.; Blusch, A.; Fatoba, O.; Brunner, J.; Pitarokoili, K.; Hayardeny, L.; Saft, C.; Gold, R., 2016:
L7Laquinimod in the R6/2 mouse model of huntingtons disease

Miralles, M.G.; Hong, X.; Caron, N.S.; Tan, L.J.; Huang, Y.; To, X.V.; Lin, R.Y.; Franciosi, S.; Papapetropoulos, S.; Hayardeny, L.; Hayden, M.R.; Chuang, K.-H.; Pouladi, M.A., 2016:
L8Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the Yac128 model of huntingtons disease

Elifani, F.; Crispi, S.; Filosa, S.; Castaldo, S.; Capocci, L.; Madonna, M.; Amico, E.; Pompeo, G.; Pompeo, F.; Brunetti, A.; Ruggieri, S.; Maglione, V.; Pardo, A.D., 2016:
L9Curcumin: a natural compound to counteract the pathology of huntingtons disease?

Singer, E.; Walter, C.; Hillmann, P.; Fabbro, D.; Riess, O.; Nguyen, H.P., 2016:
L10Two novel mtor and Pi3K/mTor inhibitors induce autophagy and reduce the amount of aggregated mutant huntingtin in cell models of Hd

Pierzynowska, K.; Hac, A.; Baranska, S.; Wegrzyn, G., 2016:
L11A novel approach for treatment of huntingtons disease by genistein-mediated stimulation of autophagy

Brokowska, J.; Hać, A.; Węgrzyn, G.; Herman-Antosiewicz, A., 2016:
L12Sulforaphane reduces the level of exogenous mutated huntingtin protein in normal human fibroblasts

Klivenyi, P.; Torok, R.; Sumegi, E.; Salamon, A.; Vecsei, L., 2016:
L13Stimulation of the Pgc-1A expression in mouse brain

Amico, E.; Martinello, K.; Draghi, F.; Cavalletti, E.; Fucile, S.; Maglione, V.; Pardo, A.D., 2016:
L14Inhibition of mitochondrial permeability transition pore (Mptp), by Gnx-4728, is beneficial in an in-vitro huntingtons disease model

Carroll, J., 2016:
A27Living with Hd: a scientists perspective

Radhia, K.; Jocelyne, C.; Sandrine, B., 2016:
L15Local striatal expression of the cholesterol degradation enzyme, Cyp46A1, in Zq175 mice: behavioural and neuropathological evaluation

Paolo, E.D.; Valenza, M.; Chen, J.Y.; Ruozi, B.; Belletti, D.; Cepeda, C.; Colombo, L.; Diomede, L.; Cagnotto, A.; Salmona, M.; Levine, M.S.; Tosi, G.; Cattaneo, E., 2016:
L16Identifying a therapeutic regimen for cholesterol delivery to huntingtons disease brain

Pardo, A.D.; Amico, E.; Castaldo, S.; Capocci, L.; Maglione, V., 2016:
L17Selective stimulation of shingosine-1-phosphate receptors (S1Prs) is beneficial in huntingtons disease pre-clinical models

Breda, C.; Sathyasaikumar, K.V.; Idrissi, S.S.; Notarangelo, F.M.; Estranero, J.G.; Moore, G.G.L.; Green, E.W.; Kyriacou, C.P.; Schwarcz, R.; Giorgini, F., 2016:
L18Tryptophan-2,3-dioxygenase (Tdo) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites

Toledo-Sherman, L.; Chachope, R.; Rose, M.; Munoz-Sanjuan, I.; Breccia, L.P.; Bate, J.; Matthews, K.L.; Wilshart, G.; Vater, H.; Jarvis, R.; Lazari, V.; Barnes, K.; Martin, S.; Blackaby, W.; McAllister, G., 2016:
L19Optimisation of potent, selective and brain penetrant atm inhibitors as potential therapeutic agents for Hd

Weber, J.J.; Ortiz-Rios, M.M.; Klumpp, L.; Kaltenbach, L.S.; Lo, D.C.; Huber, S.M.; Riess, O.; Clemens, L.E.; Nguyen, H.P., 2016:
L20Olesoxime targets calpain overactivation in models of huntingtons disease

Maschat, F.; Couly, S.; Marelli, C.; Vignes, M.; Paucard, A.; Benigno, L.; Maurel, P.; Jourdan, C.; Bonneaud, N., 2016:
L21P42, a 23Aa domain of the huntingtin protein: its protective properties and its modes of action

Fatoba, O.; Kloster, E.; Saft, C.; Gold, R.; Arning, L.; Ellrichmann, G., 2016:
L22Intranasal application of Npy and Npy1336 ameliorate disease pathology in R6/2 mouse model of huntingtons disease

Duarte, A.I.; Sjögren, M.; Santos, M.S.; Oliveira, C.R.; Moreira, P.I.; Björkqvist, M., 2016:
L23Effects of peripheral (co-)administration of liraglutide and ghrelin in the R6/2 mouse brain function

Sjögren, M.; Duarte, A.I.; McCourt, A.C.; Shcherbina, L.; Fischer, A.-H.T.én; Wierup, N.; Björkqvist, M., 2016:
L24The effect of ghrelin administration in the R6/2 mouse model of huntingtons disease

Hermant, E., 2016:
A28Living with Hd an artists perspective: alice in the huntingtonland an existential & literary project

Mena, M.Ángeles; Perucho, J.; Gómez, A.; Muñoz, M.P.; Yébene, J.G.de; Casarejos, M.J., 2016:
L25Trehalose rescues glial cell dysfunction in striatal cultures from Hd R6/1 mice at early postnatal development

Vinh, N.-N.; Roberton, V.H.; Schnell, C.; Allen, N.D.; Kemp, P.J.; Kelly, C.M.; Rosser, A.E., 2016:
L26A comparative study of human and mouse developing striatum for transplantation in huntingtons disease

Luca, G.; Calafiore, R.; Vescovi, A.; Squitieri, F., 2016:
L27Peripheral microencapsulated porcine sertoli cells for a xenograft neuroprotective treatment in huntingtons disease

Clinch, S.; Lelos, M.; Busse, M.; Rosser, A., 2016:
L28Brain repair in huntingtons disease: optimizing and assessing graft functionality post transplantation

Bartley, O.; Choompoo, N.; Vinh, N.N.; Williams, N.; Precious, S.; Kelly, C.; Rosser, A., 2016:
L29Utilising the intrinsic epigenetic memory of induced pluripotent stem cells to enhance cell replacement therapy for huntingtons disease

Testa, C., 2016:
M1Deutetrabenazine: update on first time use of Sd-809 in huntingtons disease (First-Hd) and alternative for reducing chorea in huntingtons disease (Arc-Hd)

Bonneau, D.; Bachoud-Lévi, A.-C.; Durr, A.; Goizet, C.; Azulay, J.-P.; Simonin, C.; Tranchant, C.; Calvas, F.; Krystkowiak, P.; Olivier, A.; Saudou, F.; Maison, P.; Allain, P.; Verny, C., 2016:
M2A randomised, double-blind, placebo-controlled trial evaluating cysteamine in huntingtons disease

Gelderblom, H.; Wüstenberg, T.; McLean, T.; Mütze, L.; Fischer, W.; Saft, C.; Hoffmann, R.; Süssmuth, S.; Schlattmann, P.; Duijn, E.van; Landwehrmeyer, B.; Priller, J., 2016 :
M3Study participation but not the antidepressant bupropion reduces apathy in huntingtons disease

Bohlen, S.; Mühlbäck, A.; Marquard, R.; Saß, C.; Reetz, K.; Schiefer, J.; Saft, C.; Kohl, Z.; Bonelli, R.; Münchau, A.; Klebe, S.; Weindl, A.; Storch, A.; Löhle, M.; Klopstock, T., 2016:
M4Safety and tolerability of Bn82451B in huntingtons disease

Bird, A.L., 2016:
A29Living with Hd a mothers perspective

Labuschagne, I.; Poudel, G.; Kordsachia, C.; Wu, Q.; Thomson, H.; Georgiou-Karistianis, N.; Churchyard, A.; Stout, J., 2016:
M5Neural networks linked to emotion processing modulated by intranasal oxytocin in huntingtons disease gene-carriers

Heim, B.; Bajaj, S.; Marzi, R.D.; Mangesius, S.; Djamshidian, A.; Poewe, W.; Seppi, K., 2016:
M6Nabilone in huntingtons disease: a case series of five patients

Vesper, J.; Groiss, S.; Schnitzler, A.; Wojtecki, L., 2016:
M7A prospective trial for pallidal deep brain stimulation in huntingtons disease

Eddy, C.M.; Shapiro, K.; Clouter, A.; Hansen, P.C.; Rickards, H.E., 2016:
M8Transcranial direct current stimulation and cognitive training for working memory in huntingtons disease

Trinkler, I.; Monin, M.-L.; Bismuth, H.; Francisque, H.; Jauffret, C.; Khani, S.; Chéhère, P.; Salgues, J.; Gargiulo, M.; Durr, A., 2016:
M9Contemporary dance training improves motor and executive function in Hd

Salgues, J.; Chéhère, P., 2016:
M10Huntington and dance

Busse, M.; Quinn, L.; Drew, C.; Kelson, M.; Trubey, R.; McEwan, K.; Jones, C.; Townson, J.; Dawes, H.; Edwards, R.T.; Rosser, A.; Hood, K., 2016 :
M11A randomised controlled feasibility trial of a physical activity behaviour change intervention compared to social interaction in huntingtons disease

Fossmo, H.L.; Thornes, I.; Lie, A., 2016:
M13Aquatherapy for people with huntingtons disease

Cruickshank, T.; Bartlett, D.; Lampit, A.; Hoult, L.; Govus, A.; Pulverenti, T.; Rankin, T.; Reyes, A.; Domínguez D, J.F.; Kordsachia, C.; Power, B.; Newton, R.U.; Feindel, K.; Georgiou-Karistianis, N.; Ziman, M., 2016:
M14The effect of multidisciplinary therapy on cognition in premanifest huntingtons disease: an exploratory study

Nance, M.A., 2016:
A30Living with Hd: the physicians role

Gibbons, C.A.; Sadeghi, M.; Barlow-Krelina, E.; Shaikh, K.T.; Alan Fung, W.L.; Meschino, W.S.; Till, C., 2016:
M15Computerised cognitive training for individuals with early stage huntingtons disease

Simpson, J.; Craufurd, D.; Smith, A.; Eccles, F.; Peeren, S.; Rogers, D.; Skitt, Z.; Theed, R., 2016:
M16A pilot evaluation of mindfulness-based cognitive therapy for people with huntingtons disease

Bartlett, D.; Cruickshank, T.; Lazar, A.; Lampit, A.; Slater, J.; Rankin, T.; Hoult, L.; Pulverenti, T.; Govus, A.; Power, B.; Reyes, A.; Newton, R.; Hannan, A.; Eastwood, P.; Ziman, M., 2016:
M17The effect of multidisciplinary therapy on objective and subjective sleep quality in premanifest huntingtons disease

Wexler, A., 2016:
A31Remembering george huntington and his world

Wheeler, V.C.; Kovalenko, M.; Giordano, J.; Andrew, M.; Menalled, L.; Alexandrov, V.; Thiede, C.; Weidner, J.; Teichmann, K.; Tottey, W.; Cumming, S.A.; Correia, K.; Barker, D.; Lager, B.; Flynn, G., 2016:
B1Htt Cag knock-in mice with pure and interrupted repeat tracts provide insight into the role of somatic expansion in Hd pathogenesis

Ali, N.S.; Osborne, G.F.; Benjamin, A.C.; Sathasivam, K.; Neueder, A.; Howland, D.; Bates, G.P., 2016:
B3Comparison of the effect of a pure Cag repeat and mixed cagcaa repeat on the extent to which the htt gene is aberrantly spliced in knock-in mice

Bates, G.P.; Osborne, G.F.; Ali, N.; Benjamin, A.C.; Papadopoulou, A.S.; Howland, D.; Tabrizi, S.J.; Faull, R.L.M.; Myers, R.H.; Landles, C.; Neueder, A., 2016:
B4Detection of the aberrantly spliced exon 1 intron 1 htt mRna in Hd patient post mortem brain tissue and fibroblast lines

Vaskovicova, M.; Valasek, J.; Rausova, P.; Herbert, A.; Motlik, J.; Solc, P., 2016:
B5Characterisation of double strand Dna breaks response in primary cells from huntingtons disease transgenic minipig model

Zhou, Y.; Young, L.J.; Stephens, A.S.; Landles, C.; Kaminski, C.; S Kaminski Schierle, G.; P Bates, G., 2016:
B6Super-resolution fluorescence imaging of the seeding and polymerizatoin of the huntingtin exon 1 protein

Outeiro, T.F.; Miranda, H.V., 2016:
B7Glycation potentiates neurodegeneration in models of huntingtons disease

Sathasivam, K.; Paredes, C.G.; Kuhlbrodt, K.; Thiede, C.; Reindl, W.; Smith, E.J.; Benjamin, A.C.; Franklin, S.A.; Whitehouse, C.A.; Herrmann, F.; Tillack, K.; Macdonald, D.; Marchionini, D.; Bates, G.P., 2016:
B8Ablation of p62 modulates levels of soluble and aggregated mutant huntingtin and delays end-stage disease in R6/2 mice

Pacifici, R.E.; Toledo-Sherman, L.; Rose, M.J.; Park, L., 2016:
A4An overview of energy metabolism in huntingtons disease as a therapeutic target

Gómez-Escribano, A.P.; Real-Arévalo, I.; Chen, Q.; Sequedo, L.; Blanca, J.; Cañizares, J.; Millan, J.M.; Manrique, R.V., 2016:
B9unc-1/stomatin-like modulates aggregation of polyglutamines

Ghosh, R.; Wood-Kaczmar, A.; Andre, R.; Kriston-Vizi, J.; Ketteler, R.; Cole, S.; Smith, E.J.; Bates, G.P.; Tabrizi, S.J., 2016:
B10Inclusion formation in mutant Htt exon 1 expressing human neuronal cells

Stone, T.; Elliston, L.; Brooks, S.; Holmans, P.; Dunnett, S.B.; Jones, L., 2016:
B12Characterising gene expression changes in mouse lines with varying repeat lengths in Htt

Hubert, J.; Holmans, P.; Stone, T.; Jones, L., 2016:
B13Integrating gene expression changes in human huntingtons disease brain with those in mouse models of disease

Utami, K.H.; Meng Qi, B.S.; Sobota, R.M.; Pouladi, M.A., 2016:
B14Mapping cell type-specific protein interactomes of huntingtin by live biotin ligase tagging: a proof-of-concept study in human neural progenitor cells

Andre, R.; Miller, J.R.C.; Lo, K.K.; Hensman Moss, D.J.; Träger, U.; Stone, T.C.; McErlean, P.; Jones, L.; Holmans, P.; Lavender, P.; Plagnol, V.; Tabrizi, S.J., 2016:
B15Innate transcriptional dysregulation is associated with proinflammatory pathway activation in huntingtons disease myeloid cells

Mina, E.; Roon-Mom, W.van; Hettne, K.; van Zwet, E.W.; Goeman, J.J.; Neri, C.; ’tHoen, P.A.C.; Mons, B.; Roos, M., 2016:
B16Common disease signatures from gene expression analysis in huntingtons disease human blood and brain

Flower, M.; Moss, D.H.; Lo, K.K.; Miller, J.; Omen, G.-J.van; ’tHoen, P.A.C.; Stone, T.; Guinee, A.; Langbehn, D.; Jones, L.; Plagnol, V.; van Roon-Mom, W.M.C.; Holmans, P.; Tabrizi, S.J., 2016:
B17Blood transcriptome replicates dysregulation found in human huntingtons disease brain and shares an immune signature with alzheimers disease

Bragg, B.; Coffey, S.; Ament, S.; Price, N.; Carroll, J., 2016:
B18Transcriptome profiling of B6.HttQ111/+ hepatocytes in response to chemical perturbagens

Macdonald, D., 2016:
A5Rna targeted therapies, mechanisms, and the challenges of delivery in Hd

Voisin, J.; Farina, F.; Lejeune, F.-X.; Ellerby, L.M.; Neri, C., 2016:
B19Rnaseq and chipseq analysis of Foxo3 targets in an huntingtons disease human neural stem cell model

Parlato, R.; Soenmez, A.; Spieth, S.T.; Mustafa, R.; Litke, C.; Kreiner, G.; Bierhoff, H.; Tuorto, F.; Naranjo, J.; Liss, B., 2016:
B20Dissecting the role of nucleolar stress in huntingtons disease

Weydt, P.; Jesse, S.; Bayer, H.; Alpei, M.; Zügel, M.; Mulaw, M.; Malmsheimer, S.; Singh, K.; Steinacker, J.; Schumann, U.; Ludolph, A.; Scharffetter-Kochanek, K.; Witting, A.; Iben, S., 2016:
B21Ribosomal transcription is regulated by Pgc-1alpha and disturbed in huntingtons disease

Purushottam, M.; Venkatesh, S.D.; Ratna, N.; Sen, S.; Kota, L.; Moily, N.; Pal, P.K.; Jain, S., 2016:
B22Evidence for oxidative stress in huntingtons disease

Krzysztoń-Russjan, J.; Bubko, I.; Drozd, E.; Gruber-Bzura, B.M.; Anuszewska, E.A., 2016:
B23Influence of mycoplasma arginini on inflammatory response and energy metabolism in human cells with and without Htt gene mutation

Pido-Lopez, J.; Andre, R.; Benjamin, A.; Franklin, S.A.; Tabrizi, S.J.; Bates, G.P., 2016:
B24Assessment of immune system activation status during the course of disease in huntingtons disease mouse model

Kojer, K.; Hering, T.; Birth, N.; Lenk, T.; Hallitsch, J.; Parker, J.; Haider, S.; Heikkinen, T.; Kontkanen, O.; Tabrizi, S.J.; Taanman, J.-W.; Orth, M., 2016:
B25Mitochondrial fission and fusion in skeletal muscle from Hd patients and zQ175 mice

Baranska, S.; Jędrak, P.; Krygier, M.; Tońska, K.; Drozd, M.; Bartnik, E.; Sołtan, W.; Sitek, E.J.; Stanisławska-Sachadyn, A.; Limon, J.; Sławek, J.; Węgrzyn, G., 2016:
B26Differential mitochondrial Dna levels in Hd patients depending on the cell type

Wood-Kaczmar, A.; Ghosh, R.; Kriston-Vizi, J.; Smith, E.J.; Chadwick, W.; Hargreaves, I.P.; Heales, S.J.; Abramov, A.Y.; Cole, S.L.; Ketteler, R.; Bates, G.P.; Andre, R.; Tabrizi, S.J., 2016:
B27Abnormal bioenergetics in inclusion-containing mutant Htt exon 1 primary human neurons

Grosz, Z.; Szirmai, D.; Reményi, V.; Bencsik, R.; Molnár, J.M., 2016:
B28Combined replication malfunctions in huntingtons disease

Muntoni, F., 2016:
A6Rna targeted therapies the experience from Sma and Duchennes muscular dystrophy

Jędrak, P.; Węgrzyn, G.; Więckowski, M.R., 2016:
B29Alterations in mitochondrial function in huntingtons disease fibroblasts

Buck, E.; Merz, T.; Gumpp, A.; Witting, A.; Steinacker, J.; Zügel, M.; Schumann, U.; Landwehrmeyer, B.; Weydt, P.; Calzia, E.; Lindenberg, K.S., 2016:
B30Integrated mitochondrial function in human fine-needle muscle biopsies of huntingtons disease mutation carriers and in tissues of HdhQ111 mice

Nørremølle, A.; Reynolds, R.; Petersen, M.; Willert, C.; Heinrich, M.; Nymann, N.; Dall, M.; Treebak, J.T.; Björkqvist, M.; Hasholt, L., 2016:
B31Sirt1 expression, regulation and activity in R6/2 mice

Soylu-Kucharz, R.; Petersén, .; Björkqvist, M., 2016:
B32Mechanisms of muscle degeneration in huntingtons disease

Child, D.; Lee, J.; Davidson, B.L., 2016:
B33Decreased heart mass and dysregulated cardiac mTorc1 activity are associated with huntingtons disease

Melone, M.; Vidoni, C.; Castiglioni, A.; S., C.; I., C., 2016:
B34Dopamine imbalance in huntingtons disease: when the inhibition of autophagy can lead to cell catastrophe

Pasini, M.E.; Paiardi, C.; Vernizzi, L.; Valenza, A.; Licata, G.; Vitali, T.; Vanoni, M.A.; Gellera, C.; Rizzetto, M.; Taroni, F.; Mariotti, C.; Bellosta, P., 2016:
B35Glutamine synthetase-1 induces autophagy and neuronal survival in a drosophila model huntingtons disease

Russo, C.V.; Michele, G.de; Salvatore, E.; Maio, L.D.; Peluso, S.; Massarelli, M.; Roca, A., 2016:
B36Analysis of cholesterol biosynthetic pathway in huntingtons disease

Pardo, A.D.; Amico, E.; Basit, A.; Armirotti, A.; Scalabrì, F.; Pepe, G.; D’Esposito, M.; Park, B.-M.; Jeong, S.; Piomelli, D.; Maglione, V., 2016:
B37Aberrant sphingosine-1-phosphate metabolism as druggable target in huntingtons disease

Mason, M.; Flomen, R.; Bates, G.P., 2016:
B38The effect of Hdac4 reduction post-weaning on hd-related phenotypes in R6/2 mice

Chiocco, M.; Choi, V.; Graham, A.-R.; Klatte, D.; Francone, O.; Thomson, D.; Zeitler, B.; Froelich, S.; Yu, Q.; Paschon, D.E.; Miller, J.C.; Marlen, K.; Rebar, E.J.; Urnov, F.D.; Gregory, P.D., 2016:
A7Drug discovery approach for rare neurological diseases: using novel zinc finger protein technology to develop potential therapy for huntingtons disease

Farina, F.; Lejeune, F.-X.; Parmentier, F.; Voisin, J.; Nair, S.; Thery, C.; Neri, C., 2016:
B39Modelling and biological evidence for alteration of extracellular vesicles in huntingtons disease

Flament, J.; Pépin, J.; Francelle, L.; Sauvage, M.-A.C.; Longprez, L.de; Gipchtein, P.; Cambon, K.; Valette, J.; Brouillet, E., 2016:
B40In vivo imaging of brain glutamate defects in a knock-in mouse model of huntingtons disease

Virlogeux, A.; Cazorla, M.; Bruyère, J.; Christaller, W.; Genoux, A.; Charlot, B.; Saudou, F., 2016:
B41Hd on chip : reconstituting the cortico-striatal network on microfluidics to study intracellular trafficking and synaptic transmission

Graham, R.K.; Laroche, M.; Lessard-Beaudoin, M.; Garcia-Miralles, M.; Kreidy, C.; Y.-Tager, L.; Hayden, M.R.; Nguyen, H.P.; Pouladi, M.A., 2016:
B42Early olfactory behaviour deficits associated with olfactory bulb atrophy and caspase-8 activation in Hd rodent models

Soylu-Kucharz, R.; Adlesic, N.; Petersén, ., 2016:
B43Striatal neuropathology induced by hypothalamic overexpression of huntingtin fragments using adeno-associated viral vectors in mice

Barnat, M.; Humbert, S., 2016:
B44Huntingtin regulates cortical development: consequences for huntingtons disease

Fernández-Nogales, M.; Santos-Galindo, M.; Merchan-Rubira, J.; Hoozemans, J.; Rábano, A.; Ferrer, I.; Ávila, J.; Hernández, F.; Lucas, J.J., 2016:
B45Tau-positive nuclear indentations in P301S tauopathy mice

Anger, S.; Weber, J.J.; Nguyen, H.P., 2016:
B46The Hd-like type 4/Sca17 disease protein Tbp is cleaved by calpains in vitro and in vivo

Bettencourt, C.; Moss, D.H.; Flower, M.; Wiethoff, S.; Brice, A.; Goizet, C.; Stevanin, G.; Koutsis, G.; Karadima, G.; Panas, M.; Yescas-Gómez, P.; García-Velázquez, L.E.; Alonso-Vilatela, M.E.; Lima, M.; Raposo, M., 2016:
B48Dna repair pathways as a common genetic mechanism modulating the age at onset in polyglutamine diseases

Howland, D., 2016:
A8Large animal models in huntingtons disease: conceptual overview: what model to use for what purpose

Moss, D.J.H.; Pardiñas, A.F.; Flower, M.; Miller, J.; Lo, K.; Plagnol, V.; Holmans, P.; Jones, L.; Langbehn, D.; Tabrizi, S.J., 2016:
B49Genetic modifiers of huntingtons disease progression

Xu, X.; Tay, Y.; Huang, Y.; Yoon, S.-I.; Sim, B.; Ooi, J.; Utami, K.H.; Radulescu, C.; Low, D.; Loh, M.; Ginhoux, F.; Augustine, G.J.; Pouladi, M.A., 2016 :
C1Scarless gene correction in huntingtons disease patient-derived induced pluripotent stem cells

Rosati, J.; Bidollari, E.; Tardivo, S.; Marano, M.; Sabarese, G.; Altieri, F.; Vescovi, A.L.; Squitieri, F., 2016:
C2Induced pluripotent stem cells (Ipsc) as a model of huntingtons disease

Clemens, L.E.; Walter, C.; Singer, E.; Weber, J.J.; Krahl, A.-C.; Mau-Holzmann, U.A.; Rischert, N.; Nguyen, H.P., 2016:
C3Reduced cell size and enhanced cell proliferation are characteristics of sthdhq111/111 cells and should be considered as possible confounding factors

Fears, K.; Stone, T.; Elliston, L.; Bayram-Weston, Z.; Harrison, D.; Dunnett, S.B.; Jones, L.; Brooks, S., 2016:
C4Motivation and reward seeking in Hd mouse lines: possible association with ventral striatal mHtt load and dopamine receptor loss

Yu-Taeger, L.; Lamirault, C.; Doyère, V.; Riess, O.; Massioui, N.E.; Nguyen, H.P., 2016:
C5Alteration of threat processing in the bachd rat model of huntingtons disease relies on dysfunction of central amygdala

Stan, T.L.; Flunkert, S.; Kurat, S.; Clemens, L.E.; Nguyen, H.P.; Wronski, R.; Hutter-Paier, B., 2016:
C6Novel behavioural readouts of the bachd rat in the reeperbahn and barnes maze tests

Jansson, E.; Nguyen, H.P.; Riess, O., 2016:
C7The bachd rat model of huntingtons disease shows signs of fronto-striatal dysfunction in two skinner box-based tests of short-term memory

Fabry, B.; Clemens, L.E.; Flunkert, S.; Phuc Nguyen, H.H.; Wronski, R.; Hutter-Paier, B., 2016:
C8Metabolic properties of hypothalamic primary neuron cultures from bachd rats

Vidinská, D.; Vochozkova, P.; Ardan, T.; Juhas, S.; Motlik, J.; Ellederova, Z., 2016:
C9Different forms of huntingtin in various tissues of transgenic minipig model increase with age

Morton, J., 2016:
A9Leaders not followers: sheep as large models of huntingtons disease

Schuldenzucker, V.; Schubert, R.; Freisfeld, F.; Rieke, L.; Matheis, T.; Motlik, J.; Schramke, S.; Reilmann, R., 2016:
C10Behavioural phenotyping of minipigs transgenic for the huntington gene

Bohuslavova, B.; Kucerova, S.; Macakova, M.; Klempir, J.; Lavickova, R.; Krupicka, R.; Kauler, J.; Baxa, M.; Ellederova, Z.; Motlik, J., 2016:
C11Behavioural studies in Libechov minipigs with huntingtons disease; changes in behaviour, motor skills and learning

Rieke, L.; Schramke, S.; Matheis, T.; Schubert, R.; Freisfeld, F.; Motlik, J.; Schuldenzucker, V.; Reilmann, R., 2016:
C12A new setup of the discrimination test as part of an assessment battery for phenotyping minipigs transgenic for huntingtons disease

Pokorny, M.; Juhas, S.; Juhasova, J.; Klima, J.; Motlik, J.; Klempir, J.; Havlik, J., 2016:
C13Physical activity monitoring of transgenic minipigs using telemetric accelerometer

Schuldenzucker, V.; Schubert, R.; Freisfeld, F.; Rieke, L.; Matheis, T.; Motlik, J.; Schramke, S.; Reilmann, R., 2016:
C14A stress level test as part of an assessment battery for phenotyping minipigs transgenic for huntingtons disease

Hlavnička, J.; Tykalová, T.; Mačáková, M.; Baxa, M.; čmejla, R.; Motlík, J.; Klempíř, J.; Rusz, J., 2016:
C16Hoarseness can be found in vocalisations of both human as well as genetically modified minipig model of huntingtons disease

Rodinova, M.; Ondruskova, N.; Dosoudilova, Z.; Juhas, S.; Juhasova, J.; Ellederova, Z.; Motlik, J.; Hansikova, H., 2016:
C17Increased mitochondrial number, cellular stress and glycogen accumulation in heart of minipig model transgenic for N-terminal part of human mutated huntingtin

Krizova, J.; Stufkova, H.; Rodinova, M.; Macakova, M.; Bohuslavova, B.; Pavlok, A.; Ellederova, Z.; Motlik, J.; Zeman, J.; Hansikova, H., 2016:
C18The hunt for biomarkers in presymptomatic large animal model: mitochondrial metabolism in spermatozoa of transgenic minipigs modelling huntingtons disease

Vochozkova, P.; Valekova, I.; Butalova, N.; Kovarova, H.; Ellederova, Z.; Motlik, J., 2016:
C19The immune response to the N-terminal human mutant huntingtin in minipig model

Abbasi, H.; Leach, J.P., 2016:
Retrospective Study Of Status Epilepticus In Adults In Glasgow From 19962013

Kamarajah, S.K.; Sadalage, G.; Palmer, J.; Carley, H.; Maddison, P.; Sivaguru, A., 2016:
Ocular Presentation Of Myasthenia Gravis: An Audit And Natural History Cohort

Glasmacher, S.; Saha, R., 2016:
Prognosis In Parkinson Plus Syndromes A Systematic Review

Karsan, N.; Reitboeck, P.G.; Lambert, C.; Omer, S., 2016:
Palatal Tremor: 12 Cases-The Experience Of A Tertiary Neuroscience Centre

Kaski, D.; Pradhan, V.; Bronstein, A., 2016:
The Clinical Features Of Functional (Psychogenic) Eye Movements

Kelly, M.; Baig, F.; Okai, D.; Hu, M., 2016:
Creativity & Impulsivity: Painting A Picture Of Dopamine Therapy In Parkinson'S

Silvester, L.; Kobylecki, C., 2016:
Bone Health In Parkinsonism: A Quality Improvement Project

Lamb, R.; Darvell, M.; Woodside, J.; Rohrer, J.; Lees, A.; Morris, H., 2016:
Corticobasal Syndrome And Corticobasal Degeneration

Martin-Bastida, A.; Schwarz, S.; Xing, Y.; Pietracupa, S.; Burn, D.; Silverdale, M.; Bajaj, N.; Grosset, D.; Auer, D.; Paola, P., 2016:
Neuromelanin-Sensitive Resonance Imaging As A Parkinson'S Disease Biomarker

McGovern, E.; Butler, J.; Beiser, I.; Williams, L.; Quinlivan, B.; Riordan, S.O.; Reilly, R.; Hutchinson, M., 2016:
Comparing Stimulus-Presentation Methods In Temporal Discrimintation Testing

McAuley, J.; Hughes, G., 2016:
An Unusual Cause Of Parkinsonism

Swallow, D.M.A.; Malek, N.; Grosset, K.A.; Lawton, M.A.; Bajaj, N.P.; Barker, R.A.; Ben-Shlomo, Y.; Burn, D.J.; Morris, H.R.; Williams, N.; Wood, N.W.; Grosset, D.G., 2016:
Effects Of Vascular Comorbidity In Parkinson'S Disease

Pujara, P.; Rideout, J.; Carroll, C., 2016:
Improving Provision Of Parkinson'S Disease Exercise Classes

Rajwani, H.; Coebergh, J., 2016:
Progressive Supranuclear Palsy In The Elderly In A District General Hospital

Rizig, M.; Jonvik, H.; Foltynie, T.; Limousin, P.; Bhatia, K.; Warner, T.; Morris, H.; Wood, N., 2016:
Deep Phenotyping Of The G2019S Lrrk2 Mutation In Parkinson'S Disease: Ucl Cohort

Weil, R.S.; Pappa, K.; Burn, H.; Pavisic, I.; Schwarzkopf, S.; Warren, J.; Morris, H., 2016:
Change In Visual Function In Parkinson'S Disease

Bettencourt, C.; Moss, D.H.; Flower, M.; Wiethoff, S.; Giunti, P.; Durr, A.; Holmans, P.; Houlden, H.; Tabrizi, S.; Jones, L., 2016:
Dna Repair Pathways Modulate Onset In Polyglutamine Diseases

Hong, J.; Tan, M.; Rizig, M.; Brugaletta, C.; Cable, S.; Lubbe, S.; Morris, H., 2016:
Parkinson'S Families Project: Recruitment Of Familial Pd Patients Via The Bnsu

Lukic, A.; Uphill, J.; Brown, C.; Beck, J.; Poulter, M.; Campbell, T.; Adamson, G.; Hummerich, H.; Collinge, J.; Mead, S., 2016:
Rare Structural Genetic Variation In Human Prion Diseases

Olszewska, D.; McVeigh, T.; Lynch, T., 2016:
The Experience Of The First Adult Neurogenetic Clinic In Ireland

Bottomley, C.; Padania, S.; Lloyd, A.; Gary, B.; Green, C.; Adlard, N., 2016:
Uk Patient Preference For Characteristics Of Dmts In Ms

Ahmed, W.; Carroll, L.S.; Coe, J.S.; Rashid, W.; Eva, B., 2016:
Trimming The Diagnosis

Alvarez-Gonzalez, C.; A.-Philbey, K.; M., J.; T., B.; Baker, D.; G., S.; M., M.; G., G.; S., K., 2016:
Treating Multiple Sclerosis With Cladribine

Bowen, A.; Mynors, G.; Suppiah, J., 2016:
Evidence For Ms Services: Findings Of The Ms Trust'S Gemss Programme

Coles, A.; Arnold, D.; Barkhof, F.; Filippi, M.; Hartung, H.-P.; Havrdova, E.; Selmaj, K.; Margolin, D.; Thangavelu, K.; Schippling, S., 2016:
Alemtuzumab Persistently Slows Brain Volume Loss In Rrms

Daramola, O.; R., N.; M., B.; Griffiths, M.; Moxham, N.; B., L.; C., D.; S., T., 2016:
Encephalitis: Parenchymal Leucocytes In Infectious, Immune And Unknown Cause

Davis, A.; Turner, B.; Ramadhan, M.; Albor, C.; Schmierer, K.; Giovannoni, G., 2016:
The Burden Of Bladder Dysfunction In Multiple Sclerosis: A Multi-Centre Audit

Chataway, J.; Chandran, S.; Miller, D.; Connick, P.; Giovannoni, G.; Pavitt, S.; Stallard, N.; Hawkins, C.; Sharrack, B., 2016:
Recruitment In Multiple Sclerosis Trials: The Ms-Smart Experience

Doshi, A.; Plantone, D.; DeAngelis, F.; Wheeler-Kingshott, C.; Ciccarelli, O.; Chataway, J., 2016:
Exploring Cognition In Secondary Progressive Multiple Sclerosis (Spms)

Moss, D.H.; Pardiñas, A.; Flower, M.; Miller, J.; Lo, K.; Plagnol, V.; Holmans, P.; Jones, L.; Langbehn, D.; Tabrizi, S., 2016:
Genetic Modifiers Of Huntington'S Disease Progression

Elhadd, K.; Khan, S.; Gosal, D.; Woodall, A.; Nasr, E.; Sharaf, N., 2016:
Complication Rates Of Ivig In Inflammatory Neuropathy

Ellul, M.; Bonello, M.; Wieshmann, U., 2016:
Lambert-Eaton Myasthenic Syndrome In A Tertiary Neurology Centre

Giovannoni, G.; Berkovich, R.; Fernandez, O.; Wiendl, H.; Margolin, D.; Thangavelu, K.; LaGanke, C., 2016:
Alemtuzumab Improves Edss Functional Systems Scores In Rrms

Harding, K.; Hrastelj, J.; Loveless, S.; Robertson, N., 2016:
The Association Of Hla-Drb1*1501 And Disability In Multiple Sclerosis

Hussein, O.; Cajavilca, C.; Aachi, R.; Minagar, A., 2016:
New Insights On Neuromyelitis Optica

Jacob, A.; Elkommos, S.; Hamid, S.; Mutch, K.; Panicker, J.; Frank, B.; Elsone, L.; Nurmikko, T., 2016:
A New Symptom In Neurology: Neuropathic Post-Ejaculatory Pain In Nmo

Sadalage, G.; Bowen, J.; Nightingale, S.; Jacob, S., 2016:
Rituximab Use In A Patient With Anti-Ri Positive Opsoclonus Myoclonus Syndrome

Kamalathasan, S.; Ford, H., 2016:
A Novel Monitoring System For Hypothermia In Multiple Sclerosis: A Case Study

Nicholas, R.; Hanna, J., 2016:
Natalizumab Reduces Ms Relapse Rates In Uk Top Patients

Kappos, L.; Havrdova, E.; Giovannoni, G.; Khatri, B.; Greenberg, S.; Wang, P.; Elkins, J.; Giannattasio, G., 2016:
Daclizumab Hyp Vs Im Interferon Beta-1A In Ms: Neda Results From Decide

Radue, E.-W.; Giovannoni, G.; Gold, R.; Selmaj, K.; Havrdova, E.; Stefoski, D.; Sprenger, T.; Montalban, X.; Riester, K.; Ozen, G., 2016:
Daclizumab Hyp In Multiple Sclerosis: 3-Year Results From Selected

Bolton, C.; Chapman, J.; Ledingham, D.; Lewis-Smith, D.; Spyropoulos, A.; Guadagno, J.; Duddy, M., 2016:
The Newcastle Experience Of Anti-Mog Associated Disease

Low, S.; Chataway, J., 2016:
Can Liquorice Make Steroids More PalatableIn Multiple Sclerosis?

Luppe, S.; Hakobyan, S.; Evans, D.; Harding, K.; Loveless, S.; Robertson, N.; Morgan, B.P., 2016:
Complement Activation In Multiple Sclerosis And Nmo Spectrum Disorders

Mirza, F.; Das, J.; Chauhan, V.; Cooper, P.; Pace, A., 2016:
Intracerebral Haemorrhage In Normotensive Patient With Probable Neurosaroidosis

Mazibrada, G.; Garcia-Ganuza, P.P., 2016 :
Gilenya Patient Characteristics In The Uk

Mazibrada, G.; Garcia-Ganuza, P.P., 2016:
Ms Fine Study: Gilenya Real World Experience In The Uk

Panicker, J.; Phé, V.; Pakzad, M.; Haslam, C.; Gonzales, G.; Curtis, C.; Porter, B.; Chataway, J., 2016:
D-Mannose To Prevent Urinary Tract Infections In Multiple Sclerosis

Petrova, D.; Rahman, M.; Devalia, V.; Saifee, T., 2016:
Metformin Can Lead To Functional Vitamin B12 Deficiency

Chataway, J.; Chandran, S.; Miller, D.; Connick, P.; Giovannoni, G.; Pavitt, S.; Stallard, N.; Hawkins, C.; Sharrack, B.; Plantone, D., 2016:
The Ms-Smart Trial In Secondary Progressive Ms Current Update

Rekhi, E.; Pryce, A.; Sohal, M.; Dassan, P., 2016:
Cns Demyelination In Patients On Nilotinib Treatment For Cml

Sadalage, G.; Yoganayagam, N.; Jacob, S., 2016:
Use Of Plasma Exchange For Neurological Indications

Salam, S.; Dunbar, D.; Lavin, T.; Pace, A.; Mihalova, T., 2016:
Tumefactive Rebound Of Multiple Sclerosis Following Cessation Of Fingolimod

Salam, S.; Dunbar, D.; Jackson, F.; Lavin, T.; Pace, A.; Mihalova, T., 2016:
Transient Neutropenia Following Intravenous Alemtuzumab Treatment

Samaraweera, A.; South, M.; Pitiot, A.; Tench, C.; Dineen, R.; Morgan, P.; Evangelou, N., 2016:
A Prospective Study Using 3T T2* Mri Predicts Ms In Uncertain Cases

Stavrou, M.; Smith, D.; Shaw, P.; Raciborska, D.; Silber, E.; Brex, P.; Giovannoni, G.; Schmierer, K.; Turner, B., 2016:
Real World Experience Of Fingolimod In Multiple Sclerosis: The London Audit

Janarthen, V.; Warner, G., 2016:
Neuromyelitis Optica Spectrum Disorder: A Decade To Get A Diagnosis That Fits

Williams, T.; Pryce, G.; Giovannoni, G.; Selwood, D.; Baker, D., 2016:
Vsn16R A Novel Treatment For Spasticity In Experimental Multiple Sclerosis

Healy, S.; Nasser, T.; Willis, M.; Muller, I.; Harding, K.; Pickersgill, T.; Wardle, M.; Dayan, C.; Robertson, N., 2016:
Thyroid Autoimmunity Following Alemtuzumab Treatment For Ms

Wynford-Thomas, R.; Owen, H.; Mulloch, S.; Evans, P.; Conway, B.; Watson, L.; Pearson, O., 2016:
Real-World Long Term Outcomes In Natalizumab Treated Patients

Cope, T.; Sohoglu, E.; Patterson, K.; Dawson, C.; Grube, M.; Sedley, W.; Davis, M.; Rowe, J., 2016:
Meg Reveals Speech Processing Delay In Progressive Non Fluent Aphasia

Karsan, N.; B., P.; L., J.; Goadsby, P., 2016:
The Phenotype Of Premonitory Symptoms And Migraine Headache Triggered With Nitroglycerin

Varley, J.; Vincent, A.; Irani, S., 2016:
The Role Of Adaptive Immunity In Parkinsonian Syndromes

McMacken, G.; Lochmuller, H., 2016:
Adrenergic Signalling And Congenital Myasthenic Syndromes

Hoeritzauer, I.; Panicker, J.; Elneil-Coker, S.; Granitsiotis, V.; Small, D.; Statham, P.; Summers, D.; Eugenicos, M.; Carson, A.; Stone, J., 2016:
The Clinical Features And Prognosis Of Scan Negative Uro-Neurological Disorders

Sarkar, P.; Redondo, J.; Kemp, K.; Wilkins, A.; Scolding, N.; Rice, C., 2016:
Impaired Msc-Mediated Neuroglial Protection In Progressive Ms

Okonji, E.C., 2016:
Adult-Onset Neuronal Ceroid Lipofuscinosis (Kufs Disease)

Ramachandran, S., 2016:
The Role Of Numerical Cognition In Social Decision-Making

Ahmad, H.; Arshad, Q.; Roberts, R.; Patel, M.; Ham, T.; Sharp, D.; Seemungal, B., 2016:
Chronic Dizziness Post Traumatic Brain Injury: A Cross-Sectional Study

Broad, R.; Gabel, M.; Dowell, N.; Zhang, G.; Alexander, D.; Cercignani, M.; Leigh, P.N., 2016:
Correlation Analysis Of Neurite Orientation Dispersion & Density Imaging In Mnd

Cruz, P.R.; Belaya, K.; Cossins, J.; Liu, W.W.; Maxwell, S.; Petty, R.; Farrugia, M.; Walls, T.; Beeson, D.; Palace, J., 2016:
Limb Girdle Syndromes: Myasthenia Or Myopathy

Galtrey, C.; Schon, F.; Modarres, H.; Rossor, A.; Lockwood, D.; Reilly, M.; Manji, H., 2016:
Can'T Raise One Eye Brow: Does It Ring Any Norwegian Bells?

Hong, J.; Carr, A.; Shah, S.; Matthews, E.; Fiahlo, D.; Devine, H.; Hanna, M., 2016:
Precipitous Late-Onset Radiation-Induced Myopathy

Hosseini, A.A.; Chaal, S.; Mann, C., 2016:
Proximal Myotonic Dystrophy Mimicking Progressive Muscle Wasting

Sadalage, G.; Jacob, S., 2016:
Tubular Aggregates And Cylindrical Spirals In Autoimmune Limb-Girdle Myasthenia

Laura, M.; Skorupinska, M.; Bull, K.; Byrne, B.; Reilly, M., 2016:
Survey Of Pregnancy In Charcot Marie Tooth Disease Patients

Laura, M.; Ramdharry, G.; Singh, D.; Skorupinska, M.; Reilly, M., 2016:
Managing Orthopaedic Complications In Charcot Marie Tooth Disease

Lilleker, J.; Woodall, A.; Roberts, M.; Chinoy, H., 2016:
Tibialis Anterior Muscle Biopsy A Patient Reported Outcome Study

Murphy, S.; Lilleker, J.; Rothwell, S.; Betteridge, Z.; McHugh, N.; Roberts, M.; Lamb, J.; Cooper, R.; Chinoy, H., 2016:
Characterisation Of Uk Anti-Hmgcr+ Antibody Associated Myositis

Connor, A.O.'; McNamara, B.; Sweeney, B., 2016:
Diabetic Lumbosacral Radiculoplexus Neuropathy (Dlsrn) After Bariatric Surgery

Quinlivan, R., 2016:
Transition For Neuromuscular Disease

Salam, S.; Woodall, A.; Gosal, D., 2016:
Haemolytic Anaemia As A Complication Of Intravenous Immunoglobulin Therapy

Carswell, C.; Muckle, K.; Waldman, A.; Win, Z.; Malhotra, P.; Perry, R., 2016:
Florbetapir Imaging In Clinical Practice: A Retrospective Study Of 100 Patients

Zarkali, A.; Bonifacio, G.; Englezou, C.; Parsons, V.V.H.; Renshaw, H.; Ingle, G.; Manji, H.; Reilly, M.; Lunn, M.; Carr, A., 2016:
Optimising Ivig Delivery In A Tertiary Neurology Centre

Ahmed, W.; Coe, J.; Carroll, L.; Vundavalli, S.; C., T.; Saha, R., 2016:
Cll, A Rare But Treatable Cause Of Longitudinally Extensive Myelitis

AlMasri, O.; Russell, E.; O'Brien, C.; Dharia, S.; Smith, G.; Stewart, J.; McLean, B., 2016:
Audit Of Incidental Pineal Cysts Investigation In A District General Hospital

Raheem, B.; Khan, H.; Scolding, N.; Love, S.; Al-Sarraj, S.; Bhangoo, R.; Devereaux, S.; Rooney, N.; Sutak, J.; Moran, N., 2016:
Primary T-Cell Cns Lymphoma Mimicking Vasculitis

Maloney, E.; Killeen, R.; Swan, N.; Riordan, S.O.', 2016:
A Slip Of The Tongue; A Case Of Dual Diagnosis

Connor, A.O.'; McFeely, O.; Bermingham, N.; Sullivan, S.O.', 2016:
Cerebrospinal Fluid (Csf) Cytology: Factors Impacting On Diagnostic Yield

Porretta, E.; J., S.; Jordan, S.; Male, J.; E., R.; Love, S.; S., N.; Rice, C., 2016:
Safety And Utility Of Brainstem Biopsy And Resection

Salam, S.; Fardoom, P.; Milahova, T., 2016:
Take The Bitter With The Sweet

Zienius, K.; Kerrigan, S.; Harden, S.; Grant, R., 2016:
Semantic Verbal Fluency In Patients With Headache Suspicious Of Brain Tumour

Sarr-Gonzales, S.; Zarkali, A.; Bonifacio, G.; Englezou, C.; Manji, H.; Parton, M.; Hanna, M.; Lunn, M.; Reilly, M.; Carr, A., 2016:
Optimising The Ivig Service: An Audit Of Monitoring And Dosage

Hosseini, A.; Simpson, R.; Altaf, N.; Bath, P.; MacSweeney, S.; Auer, D., 2016:
Time To Use Mri For Risk Stratification In Symptomatic Carotid Stenosis?

Al-Ansari, A.; Rickards, C.; Thomas, L.; Bain, S., 2016:
Case Report: Pandysautonomia

AlMasri, O.; Housheham, E.; McLean, B., 2016:
Ebv Meningitis As A Presenting Feature Of Gata-2 Deficiency

Barritt, A.; Bunting, E.; Cooper, S., 2016:
Prevalence And Phenotype Of Extreme Intracranial Hypertension

Bogdanova-Mihaylova, P.; Murphy, R.P.J.; Walsh, R.A.; Murphy, S.M., 2016:
Underlying Genetic Cause In Cerebellar Ataxias: Evaluation Of An Irish Cohort

Cook, S.; Janarthen, V.; Warner, G., 2016:
NeoplasticVenous Outflow Obstruction; An Unusual Cause Of Cerebral Venous Sinus Thrombosis

Edwards, M.; Johnston, J., 2016:
A Thirst For Rarity? An Interesting Case Of Hypopituitarism

Truell, M.; Hinze, S., 2016:
Nead/ Functional Weakness Comorbidities & Diagnosis Effect

Hosseini, A.A.; Ailenei, E.; Sturrock, A.; Preece, M.A.; Dawson, C.; Munkacsi, C., 2016:
Hyperammonaemia In A Patient With Walking Wounded Non-Convulsive Status

Hosseini, A.; Appelton, J.P.; Carey, M.; Ramalingam, S.; Littleton, E., 2016:
Mild Immunosuppression Causing Fatal Progressive Multifocal Leukoencephalopathy

Jones, L.; Thomas, R.; Peall, K.; Massey, T.; Moat, S.; Corkill, R.; Pickersgill, T., 2016:
No Laughing Matter

Jones, L.; Johnston, A., 2016:
A Treatable But Missable Myelopathy

Kumar, G.; Mohamed, M.; Redmond, I.; Harikrishnan, S., 2016:
Peripheral Neuropathy Associated With Whipple'S Disease

Leddy, S.; Sheridan, M.; Cervera, A., 2016:
Epilepsia Partialis Continua And Cjd; An Atypical Presentation

Li, L.; Violante, I.; Ross, E.; Leech, R.; Hampshire, A.; Carmichael, D.; Sharp, D., 2016:
Brain Network Modulation With Non-Invasive Brain Stimulation

Madi, H.; Majeed, T., 2016:
Utilisation Of Simulation Training In Neurology

Mallick, S.; Janarthen, V.; Warner, G., 2016:
Recurrent Cerebral Venous Sinus Thrombosis Secondary To Eltrombopag For Itp

Marchment, D.; Rohrer, J.; Devine, H., 2016:
Next Generation Neurology

McCloskey, R.; Michael, B.; Panicker, J.; Bonello, M., 2016:
Factors Influencing The Outcome Of Lumbar Punctures. Are We Losing Our Skill Set?

McVerry, F.; Muir, K.; McCarron, M., 2016:
What Do Diagnostic Tests Tell Us In Central Nervous System Vasculitis?

Mok, T.H.; Koriath, C.; Campbell, T.; Saha, R.; Truelsen, T.C.; Parvez, A.; Collinge, J.; Mead, S., 2016:
Estimating Causality Of The Novel Prion Protein Gene Variant T201S

Mujong, D.P.; Hassan-Smith, G.; Woolmore, J., 2016:
Brain Biopsy In Cryptogenic Neurologic Disease

Nihat, A.; Mok, T.H.; Collinge, J.; Mead, S., 2016:
Assessing Cerebellar Function In Prion Disease

Randall, A.; L., A., 2016:
La Maladie Du Petit Papier: Quantitative Survey, Clinical Significance

Sharma, K., 2016:
Setting Up An Undergraduate Neurology Teaching Day: 7 Steps

Wright, S.; Cavalle-Garcia, A.; Wright, B.; Gupta, R.; Agrawal, S.; Concannon, B.; Wassmer, E., 2016:
Transition In Paediatric Neurology: A 360 Degree Perspective

Yeo, J.M.; Kaliaperumal, C., 2016:
Pineal Cyst Haemorrhage In An Anticoagulated Patient

Yoga, B.; Randall, M., 2016:
Dangers On The Road Failures In Driving Advice In Neurological Disorders

Boardman, J.; Hilditch, C.; R., G.; R.-Ebezant, H.; S., H.; W., S.; M., S.; E., H., 2016:
Foreign Material Cerebral Emboli Following Endovascular Coiling

Muhammed, K.; Yehuda, M.B.; Drew, D.; Manohar, S.; Chong, T.; Tofaris, G.; Bogdanovic, M.; Lennox, G.; Hu, M.; Husain, M., 2016:
Pupillary Reward Sensitivity Is A Marker Of Apathy In Parkinson'S Disease

Clayton, L.; Dados, A.; Simister, R.; Gill, S.; Chandratheva, A., 2016:
The Use Of Smartphone Applications In Patients Attending Tia Clinic

Ingram, G.; Hughes, T., 2016:
The Beneficial Effect Of Combining Neurology And Stroke Services

Ingram, G.; Hughes, T., 2016:
General Medical Skills On Neurology And Stroke Wards

Kinsella, J.; Lonergan, R.; Killeen, R.; McGuigan, C., 2016:
Acute Hemifield Room Tilt Illusion In Cerebral Ischaemia

Kinsella, J.; Tobin, O.; Tierney, S.; Feeley, T.; Egan, B.; Coughlan, T.; Collins, R.; O'Neill, D.; Harbison, J.; McCabe, D., 2016:
Assessment Of Platelet Reactivity With Cerebral Microemboli In Carotid Stenosis

Lavin, T.; Punter, M.; Holland, M., 2016:
The Clinical Management Of Cerebral Venous Sinus Thrombosis. A Uk Survey

Lavin, T.; Murphy, C.; Ealing, J.; Herwadkar, A., 2016:
Spinal Cord Infarction Due To Neurofibromatosis Type 1 Associated Vasculopathy

Moreton, F.; Gonzalez, M.-R.L.; Muir, K., 2016:
Using Asl Mri To Characterise Decline In Cerebral Blood Flow In Cadasil

Peatfield, R.; Jenkins, H., 2016:
Neck Vessel Dissection Following Whiplash-Type Neck Injury

Al-Rifai, M.S.; Salek-Haddadi, A., 2016:
Case Presentation: The Dancing Man From Sierra Leone

Sedehizadeh, S.; Brook, J.D.; Maddison, P., 2016:
Correlation Of Clinical And Molecular Features In Myotonic Dystrophy Type 1

Cumberbatch, M.; Cox, A., 2016:
Rapid Push Scig A Review Of 20 Patients

Hassan-Smith, G.; Mollan, S.; Davies, B.; Shaw, S.; Chavda, B.S.; Krishnan, A.; Mallucci, C.; Silver, N.; Wakerley, B.; Sinclair, A., 2016:
Interdisciplinary Consenus On The Management Of Iih In The Uk

Lilleker, J.; Rietveld, A.; Pye, S.; Lamb, J.; Roberts, M.; Cooper, R.; Pruijn, G.; Chinoy, H.; van Engelen, B.; Collaborators, M., 2016:
Implications Of Anti-Cn1A Serotype In Inclusion Body Myositis

Palace, J.; Duddy, M.; Bregenzer, T.; Piske, B.; Lawton, M.; Joel, F.Z.; Tremlett, O.H.; Boggild, M.; Robertson, N.; Lilford, R.; Tilling, K.; Ben-Shlomo, Y.; Potter, C.; Dobson, C., 2016:
The Uk Risk Sharing Scheme: Final 10 Year Analysis

Schmidt, H.; Adams, D.; Coelho, T.; Conceicao, I.; Waddington-Cruz, M.; Buades, J.; Campistol, J.; Pouget, J.; Gollob, J.; Suhr, O., 2016:
Patisiran Ph 2 Open-Label Extension Study In Familial Amyloidotic Polyneuropathy

Hassan-Smith, G.; Nicholl, D., 2016:
The Essential Neurological Examination: An Evidence-Based, Youtube Approach?

Scott, G.; Jolly, A.; Jenkins, P.O.; Lingford-Hughes, A.; Patel, M.; Goldstone, A.; Matthews, P.; Sharp, D., 2016:
The Effect Of Minocycline On Neuroinflammation After Brain Trauma

Fulton, J.; Williamson, J.; Das, K.; Doran, M., 2016:
The Phantom Menace

Bevan-Jones, W.R.; Aigbirhio, F.; Passamonti, L.; Fryer, T.; Hong, Y.; Coles, J.; O'Brien, J.; Rowe, J., 2016:
Imaging In Dementia

Madi, H.; Gall, C.; Flegg, P., 2016:
A Perplexing Plexopathy

Marchant, R.; B., E.; B., A.; Good, C.; Adams, N.; M., A.; W., M., 2016:
Hickam'S Dictum Versus Ockham'S Razor

Sadalage, G.; Yousaf, M.; Jacob, S., 2016:
Keep Your Head Down And Shake

Shanmugam, S.V.; Minhas, P.; Johns, P.; Abdel-Aziz, K., 2016:
If The Shoe Doesn'T Fit, Don'T Wear It

Arms-Williams, B.; Woodward, C.; Thomas, R.; Payne, G.; Thomas, B.; Johnston, J.A.; Pickersgill, T., 2016:
Atypical Guillain-Barr In Three Months In South East Wales

Robinson, R.; Coebergh, J.; Abdel-Aziz, K., 2016:
Paraneoplastic Anti-Gq1B Syndrome Associated With Diffuse Large B-Cell Lymphoma

Robinson, R.; Hughes, R.; Fowle, A.; Abdel-Aziz, K., 2016:
Norse Associated With Anti-Glycine Receptor Antibodies

Schon, F.; Cock, H.; Mistry, J., 2016:
Patients Should Be Active Participants In Grand Rounds But Are Students Ready?

Bramhall, N.; Jones, M., 2016:
The Acute Complications Of Melas: A Case Series

Cousins, O.; Patel, B.; Khan, U., 2016:
Cerebral Amyloid Angiopathy-Related Inflammation: A Complex Case

Fehmi, J.; Morgan, C., 2016:
Femoral Neuropathy From Iliacus Haematoma As First Presentation Of Haemophilia

Galtrey, C.; Patel, B.; Styles, J.; Nirmalananthan, N.; Pereira, A., 2016:
Inter-Professional Neurology Simulation Training

Hoeritzauer, I.; Carson, A.; Stone, J., 2016:
Cryptogenic Drop Attacks Revisited

Hurford, R.; Bhuller, C.; Bright, L.; Crawley, F., 2016:
Are Neurologists Missing The Point?

Jones, M., 2016:
The Essential Neurological Examination For Acute Physicians

Lavin, T.; Punter, M.; Holland, M., 2016:
Service Provision For Cerebral Venous Sinus Thrombosis. A Uk Survey

Moloney, P.; Bradley, M.; Maloney, E.; Riordan, S.O.'; Connolly, S.; McGuigan, C., 2016:
An Incidental Dumbbell Prang?

Thompson, A.; Blackwell, V.; Marsden, R.; Lawson, C.; Brooks, J.; Nickol, A.H.; Talbot, K.; East, J.E.; Allan, P.; Turner, M.R., 2016:
A Risk-Stratifying Tool To Enable Late-Stage Peg Insertion In Mnd

Boodhoo, A.; Motazed, R.; Schon, F.; Nitkunan, A., 2016:
Acute Neurology Service-2 Year Study Showing Impact Of A Dgh Nurse Coordinator

Pegg, E.; Tanveer, R.; Lekuwwa, G.; Mills, R.; Emsley, H., 2016:
Diabetic Polyradiculoneuropathy Presenting With Myoclonus

Randall, A.; Aji, B., 2016:
Measurement Of Forced Vital Capacity (Fvc) In Acute Neuromuscular Weakness

Woodward, C.; Wynford-Thomas, R.; Wardle, M., 2016:
A Case Of The Several-Year Itch

Blackburn, D.; Yifan, Z.; Bell, S.; Marco, M.D.; He, F.; Wilkinson, I.; Farrow, T.; Venneri, A.; Sarrigiannis, P., 2016:
Qeeg Can Distinguish Patients With Ad And Volunteers

Clark, C.; Golden, H.; McCallion, O.; Nicholas, J.; Cohen, M.; Mummery, C.; Schott, J.; Warren, J., 2016:
Expectation And Reward In Dementia: The Case Of Music

Clarke, N.; Barrick, T.; Garrard, P., 2016:
Dti Segmentation In Focal Cortical Neurodegenerative Syndromes

Day, J.; Torrens, L.; Bowman, P.; Shepherd, M.; Chakera, A.; Hattersley, A.; Zeman, A., 2016:
Kcnj11 Mutations Cause Severe Neuropsychological Deficits

Williams, S.; Khalil, M.; Davey, R., 2016:
A Comparison Of Lumbar Puncture With And Without Bedside Ultrasound

Hosseini, A.A.; Ispoglou, S.; Hayton, T.; Evans, R.; Wilson, M.; Sawlani, V.; Rotshtein, P.; Auer, D.P., 2016:
The Role Of Hippocampal Pathology In Post-Stroke Cognitive Impairment

Koriath, C.; Adamson, G.; Druyeh, R.; Kenny, J.; Rossor, M.; Schott, J.; Collinge, J.; Fox, N.; Rohrer, J.; Mead, S., 2016:
Probing Ftd Genetics With Next-Generation Sequencing

Larner, A., 2016:
M-Ace Versus Moca: Comparative Study

Heron, C.L.; Manohar, S.; Muhammed, K.; Drew, D.; Blake, A.; Jackson, M.; Husain, M., 2016:
A Common Mechanism Underlying Apathy Across Neurological Disorders

Sharma, K.; Munro, G.; Ankrett, S.; Davis, T.; Coulthard, E., 2016:
The De-Caff Study: Caffeine In Cognitive Impairment

Williamson, J.; Larner, A., 2016:
Fibromyalgia In The Cognitive Disorders Clinic

Wojtowicz, A.; Larner, A., 2016:
Scoring Errors In Cognitive Screening Instruments Administered In Primary Care

Giffin, N., 2016:
Epidemiology Of Cluster Headache In A Dgh Headache Clinic

Amin, S.; Lux, A.; Calder, N.; Laugharne, M.; Osborne, J.; O'Callaghan, F., 2016:
Causes Of Mortality In Individuals With Tuberous Sclerosis Complex (Tsc)

Hornby, C.; Botfield, H.; O'Reilly, M.; Markey, K.; Scotton, W.; Tomlinson, J.; Arlt, W.; Sinclair, A., 2016:
Characterising Fat Distribution And Response To Weight Loss In Iih

Karsan, N.; P., P.; G., P.J., 2016:
Characterisation Of The Premonitory Stage Of Migraine In Paediatric Migraineurs

Roper, L.; Nightingale, P.; Su, Z.; Belli, A.; Sinclair, A., 2016:
Disability From Post-Traumatic Headache Is Compounded By Ptsd

Barritt, A.W.; Merve, A.; Epaliyanage, P.; Aram, J., 2016:
Mass On Scan Or Masson Scan

O'Brien, T.; Patten, A.; Bibbiani, F.; Yang, H.; Williams, B.; Laurenza, A., 2016:
Perampanel Treatment For Generalised Tonic-Clonic Seizures

Holtkamp, M.; McMurray, R.; Sousa, R.; Kockelmann, E., 2016:
Real-World Data On Eslicarbazepine Acetate: The Epos Study

Karlsson, C.; McMurray, R.; Sousa, R.; Holtkamp, M., 2016:
Real-World Data On Eslicarbazepine Acetate In Elderly Patients

Fitzsimmons, S.; Page, L.; Aram, J., 2016:
Diagnosis Is Key: Acute Hospital Management Of Nonepileptic Seizures

Islim, A.; Kemp, G., 2016:
Simultaneous Eeg-Fmri As A Pre-Surgical Evaluation Tool In Focal Epilepsy: A Systematic Review

Lovegrove, E.; Saha, A.R., 2016:
Pregnancy In Women With Epilepsy; Can We Communicate Better?

Mallam, E.; Bovill, B.; Faulkner, H., 2016:
Common But Rare: A Case Of Late Presentation Due To Neurocysticercosis

Parsons, G., 2016:
Missing A Beat: An Arresting, Overlooked Cause Of Seizures

Ridsdale, L.; Goldstein, L.; Noble, A.; Richardson, M.; Taylor, S.; Robinson, E.; Wojewodka, G.; Landau, S., 2016:
An Rct Of Self-Management Education In Epilepsy: Participants At Baseline

McMurray, R.; Kerr, M.; Sousa, R.; Holtkamp, M., 2016:
Real-World Data On Impact Of Eslicarbazepine Acetate On Qol

McMurray, R.; Karlsson, C.; Sousa, R.; Holtkamp, M., 2016:
Eslicarbazepine Acetate In Previous Carbamazepine Non-Responders

Dobrinsky, C.; Ettinger, A.; Rosenfeld, W.; Williams, B.; Laurenza, A.; Yang, H.; Patten, A.; Bibbiani, F., 2016:
Psychiatric/Behavioural Events With Perampanel Treatment For Pgtcs

Derambure, P.; McMurray, R.; Sousa, R.; Holtkamp, M., 2016:
Eslicarbazepine Acetate As Add-On To Different Aed Monotherapies

Harding, K.; Williams, O.; Willis, M.; Wardle, M.; Pickersgill, T.; Robertson, N., 2016:
Contemporary Analysis Of Mortality In Multiple Sclerosis

Waite-Taylor, F.; Jones, T.; Cock, H., 2016:
Is Epilepsy Care In Low-Grade Glioma Patients Meeting Best Practice?

Wieshmann, U.; Baker, G., 2016:
Efficacy And Adverse Effects Of Anti Epileptic Drugs

Lim, S.; Akay, E.; Singhal, S., 2016:
Audit On Second Line Treatment Of Convulsive Status Epilepticus (Cse)

Blight, B.; Davis, J.; Evans, V.; Hawkes, N.; Carroll, C., 2016:
Improving The Experience Of Diagnosis In Parkinson'S Disease

Cheng, K.; Swallow, D.; Grosset, K.; Grosset, D., 2016 :
Vascular Disease And Risk Assessment In Parkinson'S Disease

Macleod, A.; Dalen, I.; Tysnes, O.-B.; Larsen, J.P.; Counsell, C., 2016:
Development And Validation Of A Prognostic Model Of Mortality In Pd

Dominey, T.; Newman, C.; Carroll, C.; Noad, R.; Appleyard, B.; Deeprose, C.; Hall, S., 2016:
Pd-Tap: An Objective And Automated Measure Of Parkinson'S Disease Severity

Drazyk, A.; W., L.; K., R.; K., J.; M.Guigan, C., 2016:
Recurrent Hemichorea As A Marker Of Glycaemic Control

Gabel, M.; Tsermentseli, S.; Goldstein, L.H.; Al-Chalabi, A.; Young, A.; Alexander, D.; Leigh, P.N.; Cercignani, M., 2016:
Cognitive Impairment Occurs Before Loss Of Function In Als

Buenz, E.J.; Parry, G.J.; Bauer, B.A.; Howe, C.L.; Hammond-Tooke, G.; Tsuchihara, T.; Kanzaki, M.; Peacey, M., 2017:
A potential therapeutic for chronic pain from the new zealand native stinging nettle urtica ferox (ongaonga)

Dalen, C.T.; Bourke, D.; Rosemergy, I., 2017:
Glycaemic chorea

Park, J.S.; Klein, C.; Sue, C.M., 2017:
Single heterozygous mutations in atp13a2 cause mitochondrial dysfunction

Jhaveri, D.; Swayne, A.; Brown, H.; Airey, C., 2017:
A case of severe optic neuropathy caused by biopsy proven cll without peripheral transformation with excellent treatment response to rituximab, obinutuzumab (second generation anti-cd20 monoclonal antibody) and chlorambucil

Ling, H.; Morris, H.; Neal, J.; Lees, A.; Hardy, J.; Hotlon, J.; Revesz, T.; Williams, D., 2017:
1115Chronic traumatic encephalopathy in retired footballers with dementia

Holmes, E.; Baker, G.; Jacoby, A.; Ring, A.; Marson, A.; Hughes, D., 2017:
1151Patients preferences for anti-epileptic drugs (aeds)

Murley, A.; Winer, J., 2017:
1103Does slow escalation of steroid dose reduce the risk of deterioration in patients with a myasthenic crisis?

Zarkali, A.; Cheng, A.; Dados, A.; Simister, R.; Chandratheva, A., 2017:
1115Undertreatment of vascular risk factors in patients presenting with ischaemic ocular events: results from 395 patients in a tertiary centre

Lee, Y.; Hayton, T., 2017:
1700Acute neurology service: who should be seen and when?

Rodrigues, F.B.; Duarte, G.S.; Silva, M.A.; Fernandes, R.M.; Abreu, D.; Mestre, T.; Costa, J.; Trenkwalder, C.; Ferreira, J.J., 2017:
Po104Placebo and nocebo responses in rls: a meta-analysis

Kreilkamp, B.A.K.; Das, K.; Wieshmann, U.; Biswas, S.; Tyler, K.; Kiel, S.; Gould, S.; Marson, A.G.; Keller, S.S., 2017:
1724Mri-analysis in patients with non-lesional epilepsy

Clark, C.; Foster, O.; Dobson, R.; Blain, C., 2017:
Po119When you cant always get what you want.

Hosty, J.; Patil, A.; Jenkins, T.; Shaw, D.P., 2017:
1736Diagnostic classification of lower motor neuron disorders

Tan, R.Y.; Gräf, S.; Markus, H.S., 2017:
1748Screening for monogenic cerebral small vessel disease using whole genome sequencing

Hosseini, A.A.; Simpson, R.J.; Altaf, N.; Bath, P.M.; MacSweeney, S.T.; Auer, D.P., 2017:
1800Brain and carotid mri for stroke prediction in symptomatic carotid artery disease

Van Eijk, J.; Dalton, H.R.; Ripellino, P.; M., R.G.; Jones, C.; F., M.; G., C.; M., G.; P., E., 2017:
1700Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy (hev-na); an international multicentre retrospective comparative study

Binks, S.N.M.; Jacob, S.; Maddison, P.; Coebergh, J.; Isabel Leite, M.; I., S.R., 2017:
1712Less contented as a person: preliminary data from the lgi1-qol study

Gane, A.B.; Selvaraj, B.T.; Chandran, S., 2017:
Po172The unfolded protein response of ipsc-derived motor neurons in mnd

Hilz, M.J.; Leal, C.deR.; Roy, S.; Liu, M.; Hösl, K.; Wang, R., 2017:
1127Autonomic and cognitive impairment after traumatic brain injury

Tucker, H.; Shaunak, S., 2017:
1724Pcp prophylaxis in neurology a review of the incidence of opportunistic infection in patients with myasthenia gravis

Milinis, K.; Tenant, A.; Young, C., 2017:
1736Development and validation of spasticity index amyotrophic lateral sclerosis (si-als)

Nevitt, S.; Sudell, M.; Weston, J.; Smith, C.T.; Marson, A., 2017:
1748Antiepileptic drug monotherapy: a network meta-analysis of 10 aeds

Grunewald, R.; Dickson, J.; Hick, J.; Jacques, R.; Campbell, M.; Morley, R.; Reuber, M.; Dickson, J.M.; Hick, J.; Jacques, R.; Grünewald, R.A.; Campbell, M.J.; Morley, R.; Reuber, M., 2017:
1800Uk unscheduled admissions for adults with suspected seizures

Scotton, W.; Botfield, H.; Uldall, M.; Westgate, C.; Mitchell, J.; Jensen, R.; Sinclair, A., 2017:
1545Topiramate is as effective as acetazolamide at lowering intracranial pressure in healthy rodents

Bose, P.; Karsan, N.; Zelaya, F.; Goadsby, P., 2017:
1557Alterations in cerebral blood flow during the postdrome phase of a migraine attack captured with arterial spin labelled (asl) mri

McColgan, P.; Seunarine, K.; Gregory, S.; Razi, A.; Papoutsi, M.; Scahill, R.; Clark, C.; Rees, G.; Tabrizi, S., 2017:
1609Length of white matter connexions determine their rate of atrophy in premanifest huntingtons disease

Rinaldi, S.; Clark, A.J.; Bennett, D.L.H., 2017:
1621Human sensory neuron co-cultures to model inflammatory neuropathy

Varley, J.; Piehl, F.; Andersson, M.; Lang, B.; Vincent, A.; Waters, P.; Irani, S., 2017:
1633Linear- versus conformational-protein directed autoantibodies in neuropsychiatric systemic lupus erythematosis

Lang, B.; Maddison, P.; Dettmann, I.; Adcock, J.; Buckley, C.; Leite, I.; Vincent, A.; Komorowski, L.; Waters, P.; Irani, S., 2017:
1645Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

Kersey, J.; Jackson, A.; Baker, M.R., 2017:
1139Epidural stimulation of the ventral and dorsal cervical spinal cord

Baheerathan, A.; Walters, S.; Hussain, N.; Khan, A., 2017:
0900Swirls and bright lights

Bonello, M.; Jacob, A.; Ellul, M.A.; Jefferson, S.; Barker, E.; Parker, R.; Alusi, S.H., 2017:
0912The mysterious case of a dangerous dreamless sleep and how to cure it

Willis, M.; May, K.; Hope-Gill, B.; Flood-Page, P.; Jeffrey, D.; Joseph, F.; Robertson, N., 2017:
0924Tipping the balance

Jaffer, F.; Ashraghi, M.; Nadarajah, R.; Sibtain, N.; Britton, T., 2017:
0936The curious case of the shepherd and the dogs severe acute meningovasculitis: return of the great imitator

Stevenage, M.; Theochari, E.; Johnson, D.; Warner, G., 2017:
0948(An) Exercise in diagnosing (a rare cause of) double vision

Sumangala, S.; Nikfekr, E.; George, J.; Holmes, C., 2017:
1000when you hear hoofbeats...

Talbot, K., 2017:
1825Anti-sense treatment in sma: a landmark in the therapy of motor neuron diseases

Alsaeed, M.; Harding, K.; Willis, M.; Tallantyre, E.; Wardle, M.; Pickersgill, T.; Robertson, N., 2017:
1151Ethnic minority outcomes in multiple sclerosis

Tallantyre, E.C.; Major, P.C.; Atherton, M.J.; Adam Davies, W.; P., T.P.; Harding, K.E.; Winter, M.; Robertson, N.P., 2017:
1203How common is truly benign ms?

McNaughton, H.; Singh, A.; Khan, S., 2017:
1215Japanese encephalitis epidemic in northeast india: 45 cases

Hamid, S.; Whittam, D.; Mutch, K.; Linekar, S.; Das, K.; Bhojak, M.; Solomon, T.; Jacob, A., 2017:
1115Applying the 2015 neuromyelitis optica criteria in clinical practice

Rog, D.; Oh, J.; Chambers, C.; Fox, E.J.; McCombe, P.; Otero, S.; Margolin, D.H.; Kasten, L.; Compston, D.S., 2017:
1127Pregnancy outcomes in alemtuzumab trials and registry design

Whittam, D.; Hamid, S.; Mutch, K.; Linaker, S.; Mawondo, P.; Dodd, J.; Jacob, A., 2017:
1139How effective is rituximab in nmo? a review of 50 patients

Karsan, N.; Bose, P.; Thompson, C.; Goadsby, P., 2017:
Po066Alterations in attention, fatigue and alertness associated with the premonitory and postdrome stages of triggered migraine attacks

Bird, J., 2017:
1Origins of neuropsychiatry/bnpa

Voon, V., 2017:
10Impulse control disorders in parkinsons disease

Welch, K., 2017:
11Cognitive and behavioural effects of chronic alcohol excess

Tracey, M.I., 2017:
13Advanced neuroimaging of pain, analgesia and anaesthesia induced altered states of consciousness

Loane, C.; Roca-Fernandez, A.; Lage-Martinez, C.; Ahmed, S.; Butler, C.R., 2017:
14Neurobehavioural characteristics of limbic encephalitis associated with voltage-gated potassium channel complex antibodies

Misselbrook, T.; Patel, R.; Nicholson, T.; Cullen, A.; Pollak, T., 2017:
15Organic psychosis: using electronic patient records to investigate demographics, aetiology and outcome

Irani, S., 2017:
17Autoantibody-mediated encephalitis

Sharp, D.J., 2017:
19Brain imaging after tbi

Lees, A.J., 2017:
2Movement disorders the parkinsons nvrose

Ward, N., 2017:
20Neural plasticity for functional rehabilitation after stroke

Carson, A., 2017:
21Concussion, chronic trauma encephalopathy and dementia what the newspapers say and what we really (dont) know

Rossor, M., 2017:
23Dementia: thirty years back and forth

Owen, T.R.H.L., 2017:
24In sickness and in power

Dearden, J.; Medford, N., 2017:
1Functional neurological symptoms following childhood sexual abuse: the role of depersonalisation

Silva, B.; Moniz, E.; Barahona-Corrêa, B., 2017:
2Psychiatric comorbidity and quality of life in drug-resistant epilepsy

To, B.; Morris, L.S.; Baek, K.; Chang-Webb, Y.-C.; Mitchell, S.; Strelchuk, D.; Mitchell, S.; Strelchuk, D.; Mikheenko, Y.; Phillips, W.; Zandi, M.; Jenaway, A.; Walsh, C.; Voon, V., 2017:
3Disrupted avoidance learning in functional neurological disorder

McCarron, R., 2017:
4A review of methods used for determining novel psychiatric research diagnoses in children and adolescents after acquired brain injury, and their limitations

Cronin, T., 2017:
5Screening of cardiovascular risk factors in patients on antipsychotic medication

Stone, J., 2017:
3After freud the history of hysteria, conversion and functional disorders in neurology in the 20th century

Demartini, B.; Ferrucci, R.; Goeta, D.; Ruggiero, F.; Priori, A.; Gambini, O., 2017:
6Patients affected by functional motor symptoms are not liars: an experimental deception study with the guilty knowledge task

Williams, I.A.; Howlett, S.; Levita, L.; Reuber, M., 2017:
7Changes in emotion processing associated with brief augmented psychodynamic interpersonal therapy for functional neurological symptoms

Rawlings, G.H.; Brown, I.; Stone, B.; Reuber, M., 2017:
8Patients perspectives of living with epilepsy or psychogenic non-epileptic seizures: a thematic analysis investigating patients writings

Black, L.; Rickards, H., 2017:
9Is apathy a problem in huntingtons disease? a systematic review of the evidence

Leighton, D.; Manson, L.; McHutchison, C.; Sherlock, L.; Newton, J.; Abrahams, S.; Chandran, S.; Pal, S., 2017:
11Premorbid neuropsychiatric disease in patients with motor neurone disease in scotland

Ahmed, S.; Irish, M.; Loane, C.; Baker, I.; Husain, M.; Thompson, S.; Blanco, C.; Mackay, C.; Zamboni, G.; Foxe, D.; Hodges, J.R.; Piguet, O.; Butler, C.R., 2017:
12Characterising remote memory in posterior cortical atrophy

Pick, S.; Mellers, J.D.C.; Goldstein, L.H., 2017:
13Attentional bias to facial emotion in individuals with dissociative seizures is not attributable to anxiety, depression or cognitive deficits

Moughal, S.; Coebergh, J.A., 2017:
14Analysis of spiral drawings as a means of exploring differences between functional and essential tremor: an ink and paper approach

Pandis, C.(C.); Poole, N., 2017:
15Capgras delusion: a meta-analysis of case reports in the english language

Trimble, M.R., 2017:
4Epilepsy the key that unlocked neuropsychiatry

Warren, N.; O’Gorman, C.; Lehn, A., 2017:
17Dopamine dysregulation syndrome: a systematic review

Lad, M.; M., S.; G., T., 2017:
18Recall deficits with preserved recognition memory in limbic encephalitis

Dichard-Head, K.; Hunt, H.; Smith, M.; Crabb, A.; Slaght, S.; Abe, A.-M., 2017:
19Non-epileptic attacks: establishing the patient population presenting to university hospital southampton

Bindman, D.; Foong, J., 2017:
21Liaison psychiatry for neuropsychiatrists: experience from the national hospital of neurology and neurosurgery

Jain, D.; Foy, K., 2017:
22Psychiatric co-morbidity of patients referred to a neuropsychiatry clinic with functional neurological symptoms

Savage, S.A.; Butler, C.R.; Baker, J.; Hodges, J.R.; Zeman, A.Z., 2017:
23Long-term follow-up in transient epileptic amnesia: prognosis over 1020 years

Blackman, G.; Dalrymple, A.; Hanrahan, J.; Peachey, G.; Curtis, V., 2017:
24Is it feasible to use routine clinical records to investigate biomarkers in schizophrenia and related disorders

Teodoro, T.; Edwards, M.J.; Isaacs, J., 2017:
25A systematic review of brain fogs: are these functional cognitive disorders?

Owen, V.; Mortimer, C., 2017:
27Functional neurological presentation: a psychological intervention

Blackburn, D.; Percox, F.H.; Vivekananda-schmidt, P.; Reuber, M., 2017:
28Developing a teaching aid on dementia diagnosis using conversation analysis

Osman-Hicks, V.; Passa, M.; Miorelli, A.; Abe, A.-M., 2017:
29Diagnosing and managing non-cognitive symptoms in parkinsons disease: an audit of assessing clinicians adherence to nice guidance (cg35)

Zahn, R.; W., J.; B., R.; B., P.; M., P.; O.-Souza, S.J.de; Fontenelle, L.; Moll, J., 2017:
30Blame rebalance fmri feedback proof-of-concept trial in major depressive disorder

Koeda, M.; Watanabe, A.; Tsuda, K.; Matsumoto, M.; Ikeda, Y.; Kim, W.; Tateno, A.; Naing, B.T.; Karibe, H.; Shimada, T.; Suzuki, H.; Matsuura, M.; Okubo, Y., 2017:
31Effect of cntnap2 polymorphisms on cerebral response to human voice perception and handedness: an fmri study

Stern, J.; Rana, R.; Simmons, H., 2017:
33Tolerability of neuroleptics for tourette syndrome

Barahona-Corrêa, B.; Cotovio, G.; Ribeiro, R.; Senova, S.; Silva, V.C.; Oliveira-Maia, A.J., 2017:
34A lesion map of secondary bipolar disorder

Velosa, A.; Barbosa, R.; Silva, B.; Cotovio, G.; Mendonça, M.; Bugalho, P.; Maia, A.; Barahona-Correa, B., 2017:
35Mania after sub thalamic stimulation for parkinsons disease

Simpson, B.A., 2017:
6Neurosurgical interventions in psychiatry